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The hrp pathogenicity island (PAI) of Pseudomonas syringae encodes a type 
III secretion system (TTSS) that translocates virulence proteins, called effectors, into 
plant cells.  The whole array of effectors of different P. syringae stains and their 
activities inside the host are not known.  Furthermore, the manner in which effectors 
are selected for secretion, and how the process is regulated are not clear in P. 
syringae.  This study identified a novel effector from P. syringae pv. syringae Psy61 
using a genomic screen.  The effector was a 375 aa protein of 40.5 kDa that was 
  
designated HopPsyL.  A hopPsyL::kan mutant of Psy61 exhibited strongly reduced 
virulence in Phaseolus vulgaris cv. Kentucky Wonder, but did not appear to act as a 
defense response suppressor.  The ectopically expressed gene reduced the virulence 
of P. syringae DC3000 transformants in Arabidopsis thaliana Col-0.  HopPsyL 
appears to be a novel TTSS-dependent effector that functions as a host-species-
specific virulence factor in Psy61.  In addition, this study reports that TTSS-
dependent effectors are subject to the proteolytic degradation by Lon that appears to 
be rate-limiting to secretion.  TTSS-dependent secretion of these effectors could be 
detected from the Lon mutants.  This study found that a primary role for chaperones 
in P. syringae appeared to be protection of effectors from Lon-mediated degradation 
prior to secretion.  Distinct Lon-targeting and chaperone-binding domains were 
identified in at least one effector.  The results imply that Lon is involved at two 
distinct levels in the regulation of the P. syringae TTSS: regulation of assembly of the 
secretion apparatus and modulation of effector secretion.   Interestingly, degradation 
of P. syringae effectors was also retarded by the presence or expression of the P. 
syringae TTSS.  The protection from Lon-mediated degradation was not due to the 
assembly of the TTSS.  Rather, the results suggest the existence of a stabilizing factor 
harbored within the hrp cluster.  This study proposed that this factor functions as a 
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Chapter 1: Introduction 
 
Bacterial pathogens use very intricate and elegant methods to manipulate their hosts. 
These pathogens produce a wide variety of virulence factors that promote 
colonization and disease in the host, thereby allowing bacteria to multiply and spread.  
A common theme among bacterial pathogens is the secretion of these virulence 
factors to maximize their influence on the host.  Thus far, five different secretion 
pathways have been discovered for the transport of factors out of the bacterial cell 
[157].  Among them, the Type III Secretion System (TTSS) is one of the major export 
mechanisms for virulence factors in Gram-negative pathogens.  TTSS’s are used to 
inject proteins directly into host and manipulate defense responses by interfering with 
cell signaling [40, 86].  TTSS are closely related to the apparatus for flagellar 
synthesis, and are commonly found among Gram-negative bacteria that cause disease 
on both animals and plants [40, 86].  TTSS contribute to pathogenicity [40, 86], but in 
some cases they were shown to be necessary for symbiotic relationships with hosts 
[157].  Pathogens that depend on TTSS for virulence are usually incapable of causing 
disease if the TTSS is absent or malfunctioning [40, 86, 89] presumably because they 
cannot deliver bacterial proteins into the host cell. 
 
The current understanding of TTSS involves a translocation complex that traverses 
the bacterial membrane, produces a needle that can pierce the host cell membrane, 




(See Figure 1-1).  These delivered proteins can aid the bacterium in the evasion of 
defense responses, or alternatively in permitting the leakage of nutrients from the host 
cell.  Although much effort is currently being placed in discovering the roles of some 
of these effectors and how they influence the host (see [26, 32, 42, 94] for reviews), 
many questions persist about the mechanisms of TTSS.  For example, it is still not 
known what signals are used to target an effector to the secretion port, or once it is at 
the port how the effector is actually loaded into the system, or what triggers the 
system to physically transfer the effector into the host.  Furthermore, although it is 
known that effectors interact with a cytosolic chaperone in the bacterium, it is not 
known how this interaction facilitates secretion.  This study began as an attempt to 
understand some of the early steps in the selection of substrates for TTSS by using 
Pseudomonas syringae as a model system.  The project later matured into a study of 
the impact on the TTSS of proteolytic degradation of effectors, and the specific 
question of why effectors interact with specific chaperones.     
Structure of type III secretion systems 
 
Structurally, the TTSS shares similarity to the inner membrane components of 
flagellar biosynthesis and to the pore-forming protein involved in filamentous-phage 
assembly [40, 86].  The system is thought to span the inner and outer membrane 
analogously to the flagellar basal body [101] and form a long needle that protrudes 
out of the bacterium and into the host [40, 86] (See Figure 1-1).  For two species 





Figure 1-1.  The type III secretion system of P. syringae injects virulence factors 
into host cells.    
A schematic representation of the needle complex based on electron-microscopy 
images (see inset), with several ring structures that span the inner and outer 
membranes. The indigo protrusion is the 'needle' filament, which is thought to engage 
a bacterial pore-forming complex that can penetrate the plant cell wall and become 
lodged in the host cell membrane. The hrp/hrc gene cluster is portrayed below with 
the genes colored to represent their proposed location in the TTSS structure.  The 
virulence factors/effectors wait to be transported through the export machinery.  
Some effectors may be bound by chaperones during this wait.  This figure was 
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been visualized using electron microscopy [21, 110, 111].  It was characterized as a 
cylindrical structure composed of at least four substructures: (i) two inner membrane 
rings 40 nm in diameter that anchor the whole structure, (ii) two outer rings 20 nm in 
diameter which are in close contact with the peptidoglycan and outer membrane, (iii) 
a rod that links the two sets of rings, and finally (iv) a needle-like extension about 80 
nm in length and 8 nm in diameter that protrudes from the base (Figure 1-1). 
 
It is believed that once the system is organized, effectors arrive at the inner membrane 
rings of the TTSS, proceed to be loaded into the central channel of the translocon, and 
are then pushed through the needle out of the bacteria.  This process is similar to what 
is thought to occur during flagellar biosynthesis [132]. There, the basal body forms a 
conduit through which the flagellin monomers can travel unfolded to the distal end of 
the flagellar propeller and elongate the structure [113].  Effectors, too, are thought to 
travel unfolded through the TTSS needle since higher-order protein structures cannot 
be secreted through the system [60].  In addition, studies of TTSS in P. syringae 
provided compelling evidence that secretion must occur through the lumen of the 
needle since effectors were only visible at the tip of the TTSS needle [98, 99].     
 
Effectors are thus called because they can cause an effect in the host.  The variety of 
functions and effects of effectors is beginning to be understood, but appear to involve 
the active suppression of defense reponses, remodeling or rearrangement of the host 




the release of nutrients into the intercellular space [26, 42].  Effectors are divided into 
three functional domains.  The first domain contains the N-terminal secretion signal 
discussed below.  The second domain is the chaperone-binding domain, which is only 
present in the subset of effectors that interact with a cytoplasmic chaperone, also 
discussed below.  The third domain is the activity domain which carries out the 
function of the protein once inside the host cell.  The array of known functions and 
activities of effectors is well covered in other reviews, for example [26, 42].   
Targeting of effectors to the TTSS 
 
Targeting of secretion substrates to the TTSS is only beginning to be understood.  
Despite the increasing number of identified TTSS export substrates, no conserved 
secretion signal has been determined.  So far, two different signals within effectors 
have been identified and shown to be required for proper translocation.  The first 
signal is surrounded by controversy.  This signal was shown to be sufficient for 
export of reporter constructs in Yersinia, Erwinia, and Xanthomonas [7, 9, 145].  
Anderson et al [7] and Mudgett et al [145] propose that the signal is located in the 5’ 
end of the mRNA.  In their experiments, frameshift mutations that altered the 
sequence of the first 15 amino acids, but retained the remainder of the protein intact, 
led to reporter secretion.  They argued that since no conserved protein sequence was 
necessary for secretion the signal was most likely a stem loop structure in the mRNA 
and secretion likely to be co-translational [9], as has been proposed for flagellar 




secretion [184] implies that there must also be a mechanism for post-translational 
secretion.  Interestingly, Lloyd et al [124] showed that while frameshift mutations 
drastically reduced secretion of the reporter, changes in the mRNA sequence, but not 
in the amino acid sequence, had no effect on reporter secretion [124].  They proposed 
that the signal is contained in the N-termini of effectors and it consists of an 
amphipathic helical domain residing in the first 15-20 amino acids.  Furthermore, 
they show that even a synthetic amphipathic helix could drive secretion of a reporter 
[125].  Thus, it is possible that both targeting mechanisms are not mutually exclusive, 
but may act simultaneously.  Whether peptidic or mRNA, the signal contained in the 
first 15-20 amino acids can be recognized by heterologous TTSS, since plant 
pathogens can secrete mammalian pathogen effectors and vice versa [7, 77, 144, 164].   
The second signal is between residues 20-70 and is dependent on the presence of a 
chaperone [34], as will be discussed in greater detail below.  
 
The process of type III secretion 
 
Perhaps as a consequence of the undefined nature of the secretion signal, the manner 
in which the secretion signal is relayed to the translocation apparatus is also 
unknown.  How an effector is mounted to the secretion port and how it is pushed 
through the system are questions that remian unanswered.  From the knowledge 
gathered in flagellar biosynthesis, the soluble components of the TTSS could be 




example, FliI forms a complex with FliH that interacts with export substrates bound 
by chaperones [143] (Figure 1-2).  This complex can further interact with FlhA, and 
FlhB, two inner membrane components of the basal body of the secretory apparatus 
to provide the initial docking of the substrate-chaperone complex [204] [183] (Figure 
1-2).  As this occurs, FliI most likely hydrolyzes ATP [58], a process that could 
energize the initiation of translocation, as well as a conformational change that 
ultimately dismounts the soluble complex from the membrane.  Dismount would 
leave the pore open for secretion of other substrate complexes.  FliK, which has been 
implicated in substrate selection and as a switch mechanism for substrate specificity 
can be determined, also interacts with inner membrane components  
[106, 142].  The process appears to be similar for the virulence TTSS since there are 
homologs to most of the soluble components and inner membrane proteins of 
flagellar biosynthesis, excluding FliK (see Table 1-1).  In addition, the ATPase of 
Yersinia pestis, Shigella flexneri and enteropathogenic Escherichia coli have been 
shown to be also capable of interacting with  inner membrane components or 
chaperone-effector complexes [65, 96, 102].       
The role of chaperones in TTSS 
 
Recently, many studies have dealt with the identification and characterization of 




Figure 1-2.  The process of substrate docking and mounting in the flagellar 
TTSS. 
FliJ acts as a chaperone for an export substrate.   The FliJ—substrate complex 
interacts with the cytoplasmic components FliI (the ATPase) and FliH (the ATPase 
regulator).  The whole complex interacts with inner membrane components FlhA and 
FlhB, to dock the FliJ—substrate complex on the TTSS.  This interaction most likely 
induces ATP hydrolysis by FliI, which could provide the necessary energy for 
translocation.  After the substrate has been pushed through the system, FliJ is released 











Table 1-1.  Type III secretion components of P. syringae TTSS are conserved 
with the Yersinia pestis TTSS and flagellar biosynthesis apparatus. 
Pseudomonas 
syringae Yersinia pestis 
Flagellar 
biosynthesisa Cellular location 
HrcC YscC  Outer membrane (OM)  
HrpQ YscD FliG Inner membrane (IM)
HrcJ YscJ FliF IM/OM 
HrpE YscL FliH Cytoplasmic 
HrcN YscN FliI Cytoplasmic/ATPase 
HrcQ YscQ FliN IM 
HrcR YscR FliP IM 
HrcS YscS FliQ IM 
HrcT YscT FliR IM 
HrcU YscU FlhB IM 
HrcV YscV FlhA IM 
 YscW  OM lipoprotein 
HrpD YscK  Cytoplasmic 
HrpO YscO  Secreted 
HrpP YscP  Secreted 
 YscF  Secreted, needle subunit 
 YscE  Cytoplasmic 
 YscG  Cytoplasmic 
HrpB YscI  Secreted 
 YscX  Secreted 
 YscY  Cytoplasmic 
HrpA   Secreted 
HrpF   Cytoplasmic 
HrpG   Cytoplasmic 
HrpT   OM 
HrpK   Cytoplasmic 
HrpL   Cytoplasmic 
HrpJ   Cytoplasmic 
HrpV   Cytoplasmic 
HrpR/HrpS   Cytoplasmic 
HrpW    
HrpZ   Secreted 
   IM 
  FliO IM 
  FliM IM 




their corresponding effector [59, 156].  The reason for this necessity is not clear.  In 
some instances, the chaperone was shown to bind to the translocation domain and 
thus permit secretion.  The chaperone is thought to interact with a signal contained 
within the N-terminus of the effectors.  The interaction between the chaperone and 
the effector was sufficient to drive secretion of an effector, even in the absence of the 
first secretion signal [34].  These results imply that there must be a recognition step 
after the first signal has been processed.  This fact, along with some evidence that 
some chaperone-effector interactions form similar structures (see below) led to the 
hypothesis that the TTSS can recognize three-dimensional structures as the signal for 
secretion [20].  Secretion using this signal, however, is absolutely dependent on the 
presence of the chaperone [24].  Some effectors are not secreted at all in the absence 
of their corresponding chaperone even when the first signal is present [117, 155], thus 
underscoring the importance of chaperones in the process of secretion. 
 
An alternative manner in which chaperone may be necessary for secretion is by 
maintaining effectors in a “secretion competent” structure.  For instance, two 
chaperones were shown to form coiled-coil motif with their substrates that prevents 
higher order structures that might “clog up” the secretion port [19, 179].  
Interestingly, the manner in which both of these chaperones interact with their 
corresponding effector was very similar [20].  These results led to the exciting 
hypothesis that the chaperone-effector complex would form a three-dimensional 
structure that could act as the elusive secretion signal [20].  This hypothesis was 




[83, 132]. However, it does not seem that all chaperone-effector interactions form the 
same structure [148].  Moreover, the crystal structure of two type III effectors not 
associated with chaperones, AvrB and AvrPphB, do not overlap with any of the 
structures mentioned above [115, 205].  Therefore, although this hypothesis provides 
a novel concept in chaperone function, it may not fully describe the phenomenon. 
 
Another way in which chaperones have been implicated in secretion is through the 
regulation of transcription of effector genes.  For example, SicA has been shown to be 
required for the expression of sopE, a Salmonella effector [186].  SicA was later 
shown to act as a co-factor of InvF (an AraC/XylS family activator) and drive the 
expression of sigDE [49, 50].  SycH in Yersinia and FlgN from flagellar biosynthesis, 
in contrast, are not transcription co-factors; instead, they have a positive impact on 
effector gene transcription by sequestering transcriptional inhibitors YscM1, YscM2, 
and FlgM.  Upon binding of the chaperone to these negative regulators, secretion 
through the TTSS is possible and thus the repression is relieved [4, 30].  Lastly, 
chaperones may be necessary for secretion by virtue of their stabilizing role on 
effectors.  By binding to their respective effector, chaperones can sequester and 
protect it from proteolysis, resulting in higher levels of effector [44].  A higher 
abundance of effectors in the cytoplasm might result in a greater chance of secretion, 
thereby increasing the levels of effectors in culture supernatants.   
 
Paradoxically, as more data have been gathered about the function of chaperones, 




proposed to inhibit premature aggregation and folding of effectors in the bacterial 
cytoplasm to prevent possible enzymatic activity and maintain effectors competent 
for secretion [59, 156, 179].  However, later studies showed that the enzymatic 
activities of different effectors were still detectable even in the presence of the 
chaperone [20, 130], challenging the notion that effectors do not fold in the 
cytoplasm.  Another contradiction was found when YopE was secreted in the absence 
of its chaperone only when its chaperone-binding domain was deleted, indicating that 
somehow the chaperone was necessary for relieving an inhibition of secretion [24].  
Therefore, there is not one universally recognized function for chaperones, but rather 
it is generally accepted that their importance is based on multiple functions.    
The notion of hierarchical secretion from the TTSS 
 
What has become recently apparent, however, is that chaperones are not only 
involved in permitting an effector to be secreted, but also in determining when that 
effector is produced and/or secreted [59, 156].  With these data a model was created 
that proposes an ordered sequence for effector secretion, and states that chaperones 
are responsible for establishing this hierarchy [24].  Hierarchical secretion through the 
TTSS was not a novel concept.  For flagella, this ordered secretion had been proposed 
to explain how the system changes from secreting membrane components, to filament 
components and finally to placing the cap on the flagellum [112, 196].  In pathogens, 
the importance of hierarchical secretion lies in the idea that in order to invade and 




pathogen initially might want to induce host cell death or leakage, but does not want 
secondary and delayed defense alarms to be activated.  
 
The fact that chaperones were also involved in a feedback regulation of effector gene 
transcription and other methods of posttranscriptional regulation supported the model 
of hierarchical secretion [4, 29, 50, 198].  It appears, then, that chaperones can dictate 
when an effector is transcribed, translated, and whether the TTSS apparatus 
recognizes and secretes the effector [20].  This model, however, does not take into 
account the important observation that chaperones can stabilize effectors in the 
bacterial cytoplasm, nor does it deal with the fact that most effectors in plant 
pathogens are not associated with chaperones.   
Type III Secretion and Pathogenesis of Pseudomonas syringae  
 
Pseudomonas syringae is a fluorescent pseudomonad in the γ-subgroup of 
proteobacteria that facultatively infects a wide range of plant species.  A typical 
symptom of P. syringae infection is an initial “water soaking” (darkening of the 
tissue) at the site of infection (indicative of altered membrane physiology) followed 
by slowly developing programmed cell death, and in the some cases, a spreading 
chlorosis (yellowing of the tissue as chlorophyll is broken down) [17, 122].  Most 
agriculturally important plant species are susceptible to at least one P. syringae strain.  
However, individual P. syringae strains usually have a very limited host range and 




few varieties of a single plant species [82]. 
 
P. syringae occurs naturally on plant surfaces, and becomes pathogenic if the bacteria 
invade the intercellular space of the leaf mesophyll of susceptible plants [82, 122].  
This invasion is aided by wounding and leaf wetting [134].  Although not much is 
known of the molecular interaction between the bacterium and the plant cell, it 
appears that the bacterium adsorbs to the host cell surface, multiplies, and begins to 
produce virulence factors that contribute to symptom formation [134].  Common 
virulence factors of P. syringae strains are type III effector proteins [87, 100], 
extracellular polysaccharides [118, 165], derivatized peptide exotoxins [16, 74], and 
several plant growth hormones and cytokinins [67].  Over several days, bacterial 
populations in infected tissue can reach as high as 109 cells / g fresh weight of leaf 
tissue, but bacterial cells are found only in the intercellular spaces of the tissue.   
 
Resistance or susceptibility of a plant host to a specific P. syringae strain depends on 
the timing of the plant defense response to the initial colonization by the bacterium.  
In a susceptible plant, recognition of the pathogen and response to the infection 
occurs slowly [87].  As a result, the bacterial population is able to spread into new 
tissue before the cellular defense responses of colonized cells are activated, thus 
enabling the pathogen to spread continuously.  Eventually, large areas of leaves and 
other tissues become infected and necrosis develops due to a slowly induced 
oxidative burst and programmed cell death in the host [47, 54].  In contrast, a resistant 




and is able to prevent the spread of the infection.  The bacteria elicit a cascade of 
cellular defense responses in the cells of the resistant plant within 1-2 h that result in 
an oxidative burst and later programmed cell death (PCD).  PCD typically develops 
within 12 hours of infection [92, 109], a phenomenon called the hypersensitive 
response (HR).   
 
When the pathogenicity of P. syringae was first characterized, a genetically clustered 
set of transposon mutations were isolated that abolished virulence [121].  This region 
was called the hypersensitive response and pathogenicity (hrp) cluster because it was 
necessary for both the induction of HR and for disease [87, 120].  This cluster was 
shown to be sufficient to enable non-pathogenic bacteria to elicit a cellular response 
in plants [85].  The hrp cluster includes 7 operons containing 26 genes that encode a 
TTSS and its dedicated regulatory system.  Among TTSSs of mammalian pathogens, 
the Yersinia Ysc proteins are the closest homologs to the conserved Hrc products of 
the hrp cluster (see Figure 1-1 and Table 1-1).   Nine of these twelve genes are 
conserved components of all TTSS necessary for proper assembly and secretion 
through the translocation apparatus [23]. 
   
Expression of the P. syringae TTSS is environmentally regulated in such a manner 
that it is activated during pathogenesis [87].  Within the hrp cluster three genes, hrpR, 
hrpS, and hrpL positively regulate the expression of genes responsible for plant 
pathogenesis.  Previous work demonstrated the interaction between HrpR and HrpS 




that the activation of hrpL then induces transcription of all other hrp operons 
including, hrpK, hrpJ, hrpU, hrpC, hrpA, hopPsyA, other genes in the hrp PAI, and 
effector genes dispersed throughout the genome [201] [33, 62, 76, 206].  HrpL is an 
alternative sigma factor related to FliA, the alternative sigma factor involved in 
expression of class III flagellar genes [199] [153].  Promoters positively regulated by 
HrpL are highly conserved between P. syringae strains.  The HrpL-dependent 
promoter consists of a 12 base pair sequence, are critical to the formation of the 
binding motif of HrpL-dependent promoter [199].  According to this model, genes 
involved in the pathogenesis process appear to be under the control of a single 
transcription factor.        
 
Among the negative regulators of the P. syringae TTSS are Lon protease and HrpV.   
Lon is involved in the degradation of HrpR, and therefore, the assembly of the 
secretion apparatus [25].  Lon mutants are capable of hypersecreting effectors and 
eliciting plant defense responses in about one half the time required for wild-type 
cells.  Conditions that mimic the environment in plant tissue (amino acid starvation) 
suppress Lon-mediated degradation of HrpR, which would allow the HrpR/HrpS 
complex to form.  Interestingly, Lon has also been implicated in the regulation of 
TTSS from the SPI-1 system in Salmonella typhimurium [22, 182], suggesting that 
this mode of negative regulation might be conserved among Gram-negative 
pathogens with a TTSS.  HrpV also negatively regulates hrp expression, but this 




Type III effectors and secretion in Pseudomonas syringae  
 
Because the main role of the P. syringae TTSS is to translocate effector proteins 
directly into the plant cell host cytoplasm, identification of effectors is of great 
importance.  However, finding P. syringae effectors has been comparatively tricky 
because they are difficult to detect by biochemical methods [88, 188, 203] or by using 
molecular reporters. Thus far the only reporter useful to detect translocated effectors 
in P. syringae strains is the avirulence domain of AvrRpt2 [144], which itself is an 
effector.  The ability to identify effectors from various strains of Pseudomonas 
syringae would provide tools to characterize common and necessary factors for 
pathogenesis, and would also provide a way to study the manner in which pathogens 
adapt and evolve according to the hosts they can infect.   
 
Recently, bioinformatics and genetic methods for identifying effectors have revealed 
many novel candidate effectors (see [26, 39, 73] for review).  Analyses of the 
genomes of two P. syringae strains have indicated that individual strains encode a 
large number of effectors, at least five times more than mammalian pathogens.  By 
searching for HrpL-dependent promoters and proteins that fit a set of effector 
characteristics, the genome of P. syringae DC3000 was found to encode 58 known or 
likely effectors [39, 73, 158] and B728a is predicted to express at least 30 probable 
effectors [73].  The variety of effectors produced by each P. syringae strain could 




large vacuoles, or alternatively be due to the unique requirements to infect various 
hosts.  An interesting result from the genomic analyses of P. syringae was that the 
genes for the vast majority of effectors were not associated with genes for a candidate 
chaperone [39, 73].  However, as in other species, the known chaperones found in P. 
syringae strains were necessary for the secretion of effectors [14, 189, 193].   
Statement of Purpose 
 
When I began my research at Dr. Steven Hutcheson’s laboratory five years ago, I was 
intrigued by the controversy surrounding the TTSS export signal.  Two studies had 
been published suggesting that the secretion signal for effectors of mammalian and 
plant pathogens might be contained in the mRNA [7, 9].  Many investigators were not 
convinced by the data, and a later study showed that the mRNA sequence could be 
altered without effect on secretion of effectors, but the the proper amino acid 
sequence was absolutely necessary [124].  From studies demonstrating that 
mammalian and plant pathogen effectors could be secreted from heterologous TTSS 
[7, 77], it was proposed that the secretion signal must be at least partially conserved 
between all effectors.  However, no consensus sequence could be detected among the 
known effectors.   It was possible that the number of effectors studied until then had 
been too limited to form a large enough statistical group.  Thus, in order to determine 
whether there existed a conserved secretion signal in Pseudomonas syringae effectors 
that could be extrapolated to other TTSS, I proposed to find and characterize novel 




could act as the candidate secretion signal.  The first part of this dissertation describes 
the studies carried out for this purpose. 
 
The second part of my study, discussed in Chapter 3 and 4, was focused on 
determining the mechanisms of early substrate selection for TTSS in Pseudomonas 
syringae.  When I first arrived in Dr. Hutcheson’s laboratory, it was known that 
secretion by P. syringae appeared to be more tightly regulated than in mammalian 
pathogens [89], but the reasons for this tight regulation were not understood.  The 
initial observation that a Lon protease null mutant of P. syringae could hypersecrete 
proteins (Lisboa, K. and S.W. Hutcheson, unpublished results) prompted me to study 
whether some of the hypersecreted proteins were TTSS effectors, and if so, the 
manner in which the tight regulation of secretion was bypassed.  Given that proteases 
degrade proteins, I was interested in determining if Lon protease was directly 
responsible for the degradation of effectors in P. syringae, and in this manner 
regulated secretion through the system.  Furthermore, the roles of chaperones in 
secretion of effectors were beginning to be elucidated for other TTSS, but not in P. 
syringae.  One of these roles was the capacity to stabilize effectors in the bacterial 
cytoplasm.  Therefore, I investigated whether the role of chaperones in the hrp TTSS 
was to protect the effectors from Lon-mediated degradation to allow secretion. 
 
As a result of the initial studies delving into the roles of Lon in the regulation of 
TTSS from P. syringae, I discovered that effectors were stabilized when the hrp 




generalized stabilizing factor that could prevent Lon mediated degradation of 
effectors, similarly to chaperones, and thereby allow secretion.  The interaction 
between this generalized factor and effectors could also explain how and when 
substrates were selected for secretion in the hrp TTSS.  These studies are discussed in 
chapter 4.  







Chapter 2: Identification of a novel Pseudomonas syringae 
Psy61 effector with virulence and avirulence functions by a 
HrpL-dependent promoter trap assay. 
 
As published in Mol Plant Microbe Interact, 2004. 17(3): p. 254-62. 
Introduction 
Identification of the effectors produced by P. syringae strains was of high priority to 
clarify the secretion signal guiding effectors to the TTSS, and to understand P. syringae 
pathogenesis in general. This task, however, has been comparatively difficult.  Initially, 
genomic libraries of one strain were screened for avr genes that alter the host range of 
another strain [73, 114, 178, 191].  The products of avr genes were subsequently shown 
to encode translocated effector proteins [69, 119, 159].  In some cases, proteins detected 
in the growth medium have also been found to be secreted by the TTSS [203].  A 
randomly generated fusion to a truncated effector lacking the native secretion domain has 
also been used to identify effectors [76].  Most recently, in silico approaches were used to 
screen the genome of P. syringae pv. tomato DC3000, a pathogen of tomato and 
Arabidopsis thaliana, and the bean pathogen P. syringae pv. syringae B728a for genes 
that match a set of postulated effector characteristics [158] or carry conserved promoter 
sequences unique to the hrp regulon [62, 206].  These studies indicate that P. syringae 
strains carry numerous effector genes that are distributed throughout the genome as 




apparent “integron-like” modules [5, 33, 52, 89] and/or are found in plasmid-borne gene 
clusters [11, 97].   
 
Although these approaches have established catalogs of the effectors secreted by a few P. 
syringae strains, the effectors produced by most strains are still uncharacterized. Thus, 
the effectors that define the host range of the majority of strains have yet to be 
established. Genome analysis of multiple strains is limited by its cost, and most other 
previously employed methods are laborious.  Due to the limitations of these approaches, 
a more generally applicable method for screening previously uncharacterized P. syringae 
strains for effector genes was developed in our laboratory.  
 
Because the genes for all known or candidate effectors of P. syringae require the 
alternative sigma factor HrpL for expression [62, 201, 206], an inexpensive plate assay 
was devised to identify HrpL-dependent promoter fusions to a promoterless ‘lacZYA 
cassette based on the Lac phenotype of E. coli transformants carrying an arabinose-
inducible hrpL construct, pSHL4K .  The inducible hrpL construct was used to 
distinguish HrpL-dependent promoter fusions, which produce a Lac+ phenotype only in 
the presence of arabinose, from constitutively expressed promoters of other genes.  The 
promoter-trap assay was used to perform a partial screen of the P. syringae pv. syringae 
Psy61 genome. Twenty-two HrpL-dependent promoter fragments were identified (Pak, 
K. Senior Thesis, Sussan, T. personal communication).  These fragments revealed 
promoters for previously characterized hrp PAI operons of Psy61, effector genes 




effector.  This candidate gene was shown here to produce a translocated effector that is 
necessary for virulence of Psy61 in bean plants but elicits defense responses in other 
plants.  This work has been published in [128]. 
Results 
Identification of ORF54 
From the genomic analysis carried out previously in the lab (Pak, K. Senior Thesis, 
Sussan, T. personal communication), a potential ORF, ORF54, was identified 23 bp 
downstream of the deduced HrpL-dependent promoter (Figure 2-1).  ORF54 was 
preceded by a strong candidate ribosome binding site.  The predicted ORF54, however, 
extended past the end of the initially cloned fragment.  TAIL-PCR [123] and Inverse 
PCR [152] were used to determine the remaining sequence of the ORF.  ORF54 was 
found to encode a leucine-rich (12.8%) 375 aa protein with a predicted molecular weight 
of 40.5 KDa and a predicted pI of 8.74 (Figure 2-1) (Genbank accession number 
AY349161).  The deduced ORF54 product exhibited characteristics similar to other type 
III effectors, including an amphipathic N-terminus, high serine and isoleucine content in 
the first 50 aa, and few cysteines in the polypeptide [76, 158].  Other than an apparent 
chloroplast localization signal and two deduced transmembrane domains (residues 289-
307 and 349-369) in the carboxy-terminal region of the protein, no other similarities to 
the deduced ORF54 product were detected in the databases.   
 




Figure 2-1.  Arrangement and Sequence of ORF54. 
 
Sequence of the hopPsyL locus in Psy61.  Bases labeled in bold-type are the candidate 
hrpL-dependent promoter.  The open reading frame is italicized, and the translation is 
underneath.  hopPsyL encodes a leucine-rich (12.8%) 375 aa protein, predicted molecular 
weight of 40.5 KDa and pI of 8.74.  The Genbank accession number is AY349161.  The 
asterisk denotes the stop codon TGA.  Nucleotide sequence was obtained by primer 
walking using synthethic oligonucleotides at the CBR sequencing facility at the 




      AGGTGGCGGTGGAGTCGGCGTAACGGCAAGACGCCCTTCAGTGACGGACAG  51 
      AGACCTGTCTGTATTGGAACCGCTGTCTGCGTCGGGTCCACCAAGGGGTTT  102 
hopL: TAGGCCATGAGACCCGCCATGAACCCCATTCGTAATTCTCCGTCTTTCATC  153 
 +1:          M  N  P  I  R  N  S  P  S  F  I     
hopL: CCGCCCGCTCATTCGCCGGCAACTCAAGCGCCATCGCCTGGCACTGCGCTG  204 
 +1:   P  P  A  H  S  P  A  T  Q  A  P  S  P  G  T  A  L   
hopL: CATTCTGCAGTGGTCAGTCGCGACAGCAAGGCCGTAGCGCAGCTGCGCAAT  255 
 +1:   H  S  A  V  V  S  R  D  S  K  A  V  A  Q  L  R  N   
hopL: GAGGGCGCGCGCGCGAATAAACTGGATGCACAAGGGCACTCGCCTCTGGAC  306 
 +1:   E  G  A  R  A  N  K  L  D  A  Q  G  H  S  P  L  D   
hopL: GTCCTCGACACTATGCGTGATATCGACGAGCGCAGCCGTTCCAGTCTGCGC  357 
 +1:   V  L  D  T  M  R  D  I  D  E  R  S  R  S  S  L  R   
hopL: ATGGCATTACTGCAGTCACTCAATCCGACTGCGCAACTGGGCTATACCAAG  408 
 +1:   M  A  L  L  Q  S  L  N  P  T  A  Q  L  G  Y  T  K   
hopL: CCCGAGGCTCTGCACGGAACGCCCTGGGGCCTGGAAATCCTGCAGTCGGGA  459 
 +1:   P  E  A  L  H  G  T  P  W  G  L  E  I  L  Q  S  G   
hopL: GCGCTCAGGGGCGGTGTCAATGATGCAAAGGGTGGAACCCAGTCTCTTGAA  510 
 +1:   A  L  R  G  G  V  N  D  A  K  G  G  T  Q  S  L  E   
hopL: GGCAAGGTGTTTTTCTCTGATCGAACGCGGGAGAGTGCGAGCGCTGAAACC  561 
 +1:   G  K  V  F  F  S  D  R  T  R  E  S  A  S  A  E  T   
hopL: ACTCGTGCAGACTTNCGCAGCAAGCCCAGAGTCTATGCGAGAGGNGAGGGG  612 
 +1:   T  R  A  D  X  R  S  K  P  R  V  Y  A  R  G  E  G   
hopL: ATGCATCCCAGCAATGCTTACTCGCGCGCTCAGCAACACCGAATGGCGCAA  663 
 +1:   M  H  P  S  N  A  Y  S  R  A  Q  Q  H  R  M  A  Q   
hopL: GTGATCCTGCATGCGCTGGACAACGGCAGATCGCTCTCCACCAATGAACTC  714 
 +1:   V  I  L  H  A  L  D  N  G  R  S  L  S  T  N  E  L   
hopL: GCGCCATCGATCGAAGTGAGCAGCCCAGAGACGCTGTATATCGAAGGTGCT  765 
 +1:   A  P  S  I  E  V  S  S  P  E  T  L  Y  I  E  G  A   
hopL: GCGTGGCTGCAACGTTTACTGCATGGCGGGTACATCAATAAATTAGGCGGG  816 
 +1:   A  W  L  Q  R  L  L  H  G  G  Y  I  N  K  L  G  G   
hopL: CTCCCATTCATCAATGCCCCACTGGGCGAGCATCTGGACTCACTGAGGTTA  867 
 +1:   L  P  F  I  N  A  P  L  G  E  H  L  D  S  L  R  L   
hopL: CCTGGCTCGATTGAGTTGAGAGTCGATGGGCAGGTAAAGAAGTTACAGGGT  918 
 +1:   P  G  S  I  E  L  R  V  D  G  Q  V  K  K  L  Q  G   
hopL: GAAGAGCTGAATCGCTTTTATCATCAGGCGGCGAGTGAACTGCAGCGTTCT  969 
 +1:   E  E  L  N  R  F  Y  H  Q  A  A  S  E  L  Q  R  S   
hopL: CTGGAAAATGGCAAGGCCCCTTACCTGGGTTTGTTGAACAAGGGAGCCATT  1020 
 +1:   L  E  N  G  K  A  P  Y  L  G  L  L  N  K  G  A  I   
hopL: GTTCCACTGGTGTTCGGTTTCGAGAAAATCAACAACCTGTCTACGCATGAA  1071 
 +1:   V  P  L  V  F  G  F  E  K  I  N  N  L  S  T  H  E   
hopL: ATCAAATTACGCTCGAAAACCACACAGCACTCCTATCAGGATACCGAGCAC  1122 
 +1:   I  K  L  R  S  K  T  T  Q  H  S  Y  Q  D  T  E  H   
hopL: CCACTTGCCGGAAGTCCGGAGAATGGTGGGAAGCTGAAAGAAGTGGAGGTG  1173 
 +1:   P  L  A  G  S  P  E  N  G  G  K  L  K  E  V  E  V   
hopL: CGTAGCCTGGGTGATTTCGCCACATTGTGCCTGGGGTGCGCGGGTCAAGGG  1224 
 +1:   R  S  L  G  D  F  A  T  L  C  L  G  C  A  G  Q  G   
hopL: GCTTTGAATTGCCTACCGACATAGTCGTGCGTGTTAAAGGCCAAAAAAGCC  1275 
 +1:   A  L  N  C  L  P  T  *  
      AAAAAGCTCAGTATCTGGACGCGCAACAAATACAGGCATTTCGGCAAAACC  1326 
      TGGCAGCTCAAGTGGCCGAGCAGGCAAAGGGGAAGCCTCTGGGNACGCTCC  1377 
27 
      CTTTGCATCAGTTGCAGGAGAATCAATTCTCGACTGCGGGCTGGCGATTTA  1428 
 
 
frame in the region and ‘lacZ were constructed in pMLB1034.  Only the fusion to the 
deduced ORF54 expressed appreciable β-galactosidase activity in induced SLR400 
(pSHL4K) (Figure 2-2A).  To verify the deduced size of the gene product, an amino- 
terminal 6xHis fusion to ORF54 was constructed in pQE30.  The predicted 40 kDa 
ORF54 product was detected in immunoblots of DH5α (pLL54Q30) probed with anti-
6xHis antibody (Figure 2-2B). 
 
The ORF54 product is translocated into plant cells.   
The structural and genetic features of ORF54 suggested that this protein could be an 
effector translocated by the hrp TTSS.  To test this hypothesis, translational fusions 
between the amino terminal 46 codons of ORF54 and the carboxy terminus of ‘AvrRpt2 
were created in pDSK519 and tested in the effector translocation assay described 
previously [73, 76, 146].  In this assay, the avirulence domain of AvrRpt2 lacking the 
ability to be secreted (‘AvrRpt2) was fused to the potential secretion signal of the 
candidate effector.  If secretion and translocation of ‘AvrRpt2 occurs, an Rps2-specific 
HR would be observed only in Rps2+ plants.  Pto DC3000 (pLL54AvrRpt2K) expressing 
the fusion elicited a classic hypersensitive response (HR) in RPS2+ A. thaliana (Figure 2-
3A).  The inoculated tissue of rps2 plants developed disease symptoms by 42 h in the 
form of purple, expanding lesions (Figure 2-3A).  A null response was detected when 
these fusions were expressed in the Pto DC3000-A9 (hrpA::Ω) mutant that is incapable 
of type III secretion (Figure 2-3A).  These results are consistent with the TTSS-dependent 




Figure 2-2.  Translational Fusions Between the three possible open reading frames 
and lacZ. 
A. PCR products carrying the region with the hrpL-dependent promoter, the 
ribosome-binding site and the first 120, 121, or 122 bp of hopPsyL were cloned 
into pMLB1034, which generated a translational fusion to ‘lacZ in three distinct 
reading frames.  The constructs were assayed for β-galactosidase activity in E. 
coli SLR400 carrying pSHL1K, which expressed HrpL from an arabinose 
dependent promoter.  The expression of hrpL was induced with 0.02% arabinose.  
Lac activity was measured following the procedures of Miller [139] and 
expressed as Miller Units. 
B.  hopPsyL was amplified by PCR using specific primers (See Table 2-3) and 
cloned into pQE30 as a BamHI- HindIII fragment in frame with the 6xHis tag.  
The expression of HopPsyL6xHiswas induced with 1mM IPTG for 4 hours in 
DH5 α.  Whole cell extracts were resolved in a 12% SDS-PAGE and 
HopPsyL6xHis was visualized using the anti-His antibody and ECL 
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Figure 2-3.  HopPsyL is a translocated effector with virulence and avirulence 
functions.    
(A) AvrRpt2 translocation assay.  A truncated AvrRpt2 protein (80-255 aa, ‘AvrRpt2) 
was fused to the N-terminal 46 aa of HopPsyL (HopPsyL46::AvrRpt2).  Plasmids 
expressing the indicated proteins were introduced into DC3000 or DC3000-A9 (-hrp).  
Arabidopsis thaliana Col-0 (RPS2) or rps2- leaves were infiltrated with bacterial 
suspensions at 108 cfu/ml and evaluated for hypersensitive response (HR) after 18 h or 
disease symptoms after 42 h.  Col-0 leaves showing the HR (+) appeared wrinkled at 18 
h, rps2- leaves showing disease appeared yellow and necrotic at 42 h. (B) Responses of P. 
vulgaris cv. Kentucky Wonder to P. syringae Psy61 and the hopPsyL::kan mutant, 
Psy61-LL.  Leaves were inoculated at the indicated inoculum and photographed at 36 h.  
Note the lesions observed in tissue inoculated with Psy61 at 105 and 104 CFU/ml that are 
absent with the same levels of Psy61-LL1.  (C) Ectopic expression of HopPsyL in P. 
syringae pv tomato DC3000 abolishes symptom development in A. thaliana.  DC3000 
was transformed with plasmids expressing the indicated protein.  Bacterial suspensions of 
105 cfu/ml were used to inoculate A. thaliana Col-0 plants. The photographs were taken 
at 72 h after inoculation and were representative of developed symptoms.  Note the 
necrosis and water soaking symptoms in leaves where HopPsyL was not expressed, 










The ORF54 product was therefore designated as HopPsyL.   
hopPsyL is necessary for virulence in Phaseolus vulgaris cv Kentucky Wonder. 
 
To determine the role of HopPsyL in the virulence of Psy61, a hopPsyL::kan insertion 
was constructed in Psy61 by allelic exchange to create Psy61-LL1.  The mutation was 
confirmed by Southern hybridization analysis (Figure 2-4).  Psy61 has recently been 
reported to be a pathogen of Phaseolus vulgaris [52].  P. vulgaris cv. Kentucky Wonder 
was susceptible to Psy61 infection as demonstrated by the appearance of water-soaking 
lesions (symptom score of 4 [93]) and necrosis observed at all inoculum levels by 36 hr 
(Figure 2-3B, Psy61).  A 105-fold increase in bacterial populations detected 3 days post-
inoculation (Figure 2-5).  The mutant strain, in contrast, was considerably reduced in 
virulence.  Plants inoculated with Psy61-LL1 showed minimal water-soaking symptoms 
(Figure 2-3B, Psy61-LL1). Red-brown necrotic response, typical of resistance [93], 
developed near the inoculation site by 36 h at high inocula and macroscopic symptoms 
did not develop in tissue inoculated with less than 106 CFU/ml (Figure 2-3B, Psy61-
LL1).  Detected populations of Psy61-LL1 were 102 lower than in the parent strain at 3 
days (Figure 2-5).  Complementation of the mutant with a plasmid-borne hopPsyL 
restored virulence to the strain as indicated by the population levels detected in tissue 
(Figure 2-5).  The failure of the hopPsyL::kan mutant to develop disease symptoms and 
the reduced growth in the previously susceptible host indicate that HopPsyL is important 




Figure 2-4.  Southern Hybridization confirms hopPsyL insertion.  
 
A.  A 32P-labelled probe was generated by PCR amplification from Psy61 genomic DNA 
with primers 54-549E and 54-1247B (see Table 2-3).  Chromosomal DNA from Psy61 
and Psy61-LL1 was digested with BamHI and transferred to a charged nylon membrane.  
Membranes were allowed to hybridize to the labeled probe and washed under low 
stringency conditions [167].  Bands that hybridized to the probe were visualized by 
autoradiography.  The shift in size from the wild-type to the mutant is consistent with the 













←  6.3 Kb ←  3.4 KbPsy61    Psy61-LL1
Figure 2-5.  HopPsyL is required for virulence of Psy61 in P. vulgaris cv. Kentucky 
Wonder.   
 P. vulgaris leaves were inoculated with a 105 cfu/ml suspension of Psy61 (wild-type, 
▲), Psy61-LL1 (hopPsyL::kan, ■), or the complemented strain Psy61-LL1 expressing 
HopPsyL (♦).  The bacterial populations were monitored every 24 h by mascerating a 38 
mm2 leaf disk in 100 µl of M63 media.  The suspensions were diluted to appropriate 
bacterial concentrations and bacteria were enumerated after 24 – 30 h.  The values 
reported are the mean of 6 replicates. Error bars represent the standard deviation. The 

































HopPsyL acts as an avirulence determinant in Arabidopsis thaliana. 
 
Ectopic expression of effectors in non-native strains has been previously shown to affect 
virulence of the recipient P. syringae strains [177, 191].  The region carrying hopPsyL 
was amplified from Psy61 genomic DNA and cloned into the broad host range cosmid 
pLAFR3 to create pLL54L.  When A. thaliana Col-0 was inoculated with Pto DC3000 
(pLL54L) at 107 cfu/ml, an HR developed by 18 h.  A null response was observed at 
lower inoculum levels (Figure 2-3C, HopPsyL).  In contrast, leaves inoculated with the 
virulent Pto DC3000 (pLAFR3) developed typical disease symptoms by 42 h (Figure 2-
3C, None).  To quantify the effect of HopPsyL on the virulence of Pto DC3000, 
populations of Pto DC3000 (pLAFR3) and Pto DC3000 (pLL54L) were monitored in 
inoculated A. thaliana Col-0 leaves.  Whereas DC3000 (pLAFR3) populations increased 
104-fold during the 4 day assay period, those of DC3000 (pLL54L) increased only 500-
fold (Figure 2-6).   
 
HopPsyL does not suppress the HR. 
 
Various TTSS-dependent effectors of P. syringae strains have been recently identified 
that facilitate pathogenicity of the source strain by an apparent suppression of host 




Figure 2-6.  Ectopic expression of HopPsyL reduces the virulence of DC3000 in A. 
thaliana Col-0.   
A. thaliana leaves were inoculated with a 105 cfu/ml suspension of DC3000 carrrying 
either the empty vector pLAFR3 (♦), or a construct in pLAFR3 expressing HopPsyL (●).  
The bacterial populations were monitored every 24 h as in Figure 2-5.  The values 
reported are the mean of 6 replicates. Error bars represent the standard deviation. The 































suppressing host defense responses.  Unlike HopPtoD2, which could delay the timing of 
the HR during an incompatible host-pathogen interaction [27, 55], HopPsyL did not alter 
development of the HR of DC3000 in P. vulgaris cv Kentucky Wonder.  Bacterial 
suspension (108 cfu/ml) of DC3000 (pLAFR3) or DC3000 (pLL54L) were used to 
inoculate P. vulgaris cv Kentucky Wonder leaves and the appearance of HR was checked 
every 2 hours for the first 16 h.  No differences in phenotype or development of the HR 
elicited were detected (Table 2-1).  In addition, several non-host plants of Psy61 (see 
Materials and Methods) were challenged with high inocula of Psy61 or Psy61-LL1 and 
the timing and manifestation of the elicited HR were studied.  The induced HR was 
indistinguishable in all the hosts studied.   Taken together, these results suggest that 
HopPsyL does not suppress plant defense responses, but instead acts by another 
mechanism to facilitate parasitism of Kentucky Wonder by Psy61. 
 
Distribution of hopPsyL among P. syringae strains.   
 
To determine the distribution of hopPsyL alleles among P. syringae strains, a PCR screen 
was performed using the primers 54-549 and 54-1247.  Diagnostic fragments indicative 
of the presence of hopPsyL were amplified from six of 10 P. s. pv. syringae strains tested 
(each with distinct host range) (Table 2-2), but not from any of the P. syringae pvs. 
tomato, maculicola, or phaseolicola strains screened.  Sequence of the amplified 





Table 2-1.  The hypersensitive response is not inhibited by HopPsyL. 
 
 
Time (h)1 Psy612 Psy61-LL12 
2 nr Nr 
4 nr Nr 
6 2 2 
8 2-3 2-3 
14 3-4 3 
18 4 4 
20 4 4 
22 4-5 4-5 
24 5 5 
 
1. Leaves of Phaseolus vulgaris cv. Kentucky Wonder were inoculated with a 108 
cfu/ml suspension of Psy61 or the hopPsyL::kan mutant, Psy61-LL1.  The 
induced hypersensitive response (HR) was measured every 2 hours for water 
soaking as initial evidence of initiation of HR, and then for tissue collapse and 
necrosis.  
2.  The symptoms were scored using the following scale: nr, no reaction; 2, glazing; 


























Psy    
   61 + + D 
   B3A + + D 
   B76 + + Null 
   5D417 + + Null 
   B362 + + D 
   B382 + + Null 
   3097 + + Null 
   Ps-1 Bean - - na 
   B460 - - na 
   Ps-1 - - na 
   1053 - - na 
   WYN 108 - - na 
   S-4B-1 - - na 
E. coli  - -  
   DH5α - - na 
 
1  Strains and hosts were described in [53].  Other P. syringae pathovars were tested but 
resulted in a lack of either amplification or signal from the different assays.  Those strains 
are as follows:  pv. maculicola #1, #5, and #10;   pv. phaseolicola NK343, B130, and 
BK378;   pv. tomato T1,4355, 3523, B76, B88, B118, B121, B122, B19, and DC3000. 
2  PCR analysis was performed using primers 54-549 and 54-1247 and an annealing 




fragment.  Psy61 was used as a positive control, and DH5α as a negative control. 
3  Hybridization experiments were performed using a 698 bp probe generated using 
primers 54-549 and 54-1247 and room temperature washes in 1x SSC.  A positive sign 
indicates that hybridization of the probe could be detected in autoradiograms. 
4  Overnight cultures were diluted into fresh media and allowed to grow until the OD600 
reached 1.0.  The cells were collected, washed in M63, and respuspended at 106  cfu/ml.  
The suspension was used to inoculate Phaseolus vulgaris cv Kentucky Wonder.  The 
symptoms were scored daily up to 5 days.  D, slowly developing necrosis typical of 
disease observed at 36 h; d, slight symptoms of disease by 72 h; Null, no response 




screen for more divergent alleles, the 698 bp fragment carrying the amino terminal 
portion of  hopPsyL was amplified from Psy61 genomic DNA and used to probe the 
genomes of the selected strains for presence of an hopPsyL allele by low stringency 
hybridization.  Hybridization results mirrored those from the PCR screen.  Those strains 
that produced the indicative PCR product hybridized to the probe whereas the other 
strains did not.  An ortholog of hopPsyL was not detected in the DC3000 and B728A 
genomes.  Of the strains carrying HopPsyL, only B632, originally isolated from diseased 
beans (J. DeVey, personal communication) and B3A, isolated from a peach variety, were 
apparent pathogens of Kentucky Wonder (Table 2-2).  The contribution of HopPsyL to 
this virulence has not been established.  The observation that only a few strains carrying a 
hopPsyL allele are pathogens of bean indicates that HopPsyL does not act epistatically to 
other effectors to enable virulence in bean. 
 
Discussion 
The pathogenicity and host range of P. syringae strains have been linked to the 
expression of strain-specific arrays of effectors that are translocated into host cells by the 
hrp TTSS.  By utilizing the previous observations that all known effectors expressed by 
P. syringae strains are components of the hrp regulon [62, 201, 206], and therefore are 
dependent upon HrpL for transcription, an E. coli-based HrpL-dependent promoter trap 
screen was developed to identify candidate effector genes expressed by a strain.  The 
screen was successful in identifying several effectors previously characterized in other 




fragment carried a near consensus HrpL-dependent promoter but the associated coding 
sequence lacked similarity to other genes.  HrpL-dependent activity of the fragment was 
verified in Psy61 and the ORF identified directly downstream of the HrpL-dependent 
promoter was shown to encode HopPsyL, a 40.5 kDa protein with no homologs in the 
databases. HopPsyL was translocated into host cells by the hrp TTSS and facilitated 
Psy61 virulence in P. vulgaris cv. Kentucky Wonder.  When ectopically expressed in the 
A. thaliana pathogen DC3000, HopPsyL acted as an avirulence determinant, reducing the 
growth of the expressing strain and suppressing symptom development. 
 
The mechanisms through which HopPsyL contributes to parasitism and disease in 
Kentucky Wonder remain unknown.  No enzymatic or metabolic function could be 
assigned to HopPsyL but the structural features suggest that it may localize to 
chloroplasts as suggested for several other effectors of P. syringae strains [73, 76].  
HopPsyL is unique in that it also contains an apparent ankyrin repeat motif at residues 
36-64.   Ankyrin-like domains are thought to function in protein-protein interactions, and 
are present in some plant defense response genes, such as PR1 [170].  HopPsyL also has 
a comparatively high Leu content that could be indicative of protein-protein interactions.  
The Yersinia effector YopM, and Salmonella effectors SspH1 and SspH2 also have high 
Leucine content and carry Leucine-rich repeats [56] [138] which are used in the 
pathogenicity of both organisms.  However, leucine rich repeats were not identified in 
HopPsyL by the REP, REPRO  or Radar algorithms [10, 66, 79].  The presence of two 
separate TM domains suggests that this effector could localize to a membrane.  





In contrast to several recently characterized effectors [1, 27, 55, 78], HopPsyL does not 
appear to be a general suppressor of plant defense responses.  For instance, expression of 
the locus in the native Psy61 or in Pto DC3000 did not affect the ability of the strain to 
elicit the HR or related responses in resistant plants.  HopPsyL does not appear to act 
epistatically to other effectors to facilitate pathogenesis.  Namely, ectopic expression of 
hopPsyL in Pto DC3000 did not expand its host range to include Kentucky Wonder, and 
most strains of P. syringae that carry a homolog of hopPsyL were not pathogens of 
Kentucky Wonder.  One explanation for the role of HopPsyL in pathogenicity could be 
that it acts as a virulence gene required for Psy61 to replicate in Kentucky Wonder.  
Alternatively, HopPsyL could act to mask the activity of another avr product specifically 
active in Kentucky Wonder, similarly to the suppression of AvrPphF activity in Canadian 
Wonder by AvrPphC [185].  Consistent with this hypothesis, inactivation of hopPsyL in 
Psy61 resulted in an apparent conversion to an incompatible interaction in Kentucky 
Wonder.  Irrespective of the mechanism of action, HopPsyL can be added to a growing 
set of P. syringae effectors that are required for virulence in one host but elicit defense 
responses in another host.    
 
Unfortunately, the great number of discovered P. syringae effectors has not led us any 
closer to the clarification of the type III secretion signal.  Petnicki-Ocweija, et al. [158] 
postulated a set of common characteristics shared among type III effectors.  These 
characteristics include: 1) the first 50 amino acids of known 




proteins in P. syringae [76]; 2) the N-termini of most Hops are amphipathic and rich in 
polar amino acids; 3) they have an aliphatic amino acid (Ile, Val, or Leu) or Pro at the 
third or fourth position; 4) they have no acidic amino acids (Asp or Glu) in the first 12 
amino acids; 5)  the fifth position is rarely Met, Ile, Leu, Phe, Tyr, or Trp; 6) cysteine 
residues are rarely found after the fifth position (among the N-terminal 50 residues); and 
7) there are no more than three consecutive residues consisting of Met, Ile, Val, Phe, Tyr 
or Trp [158]. Genomic searches for ORFs with these characteristics have yielded many 
potential hop genes [76, 158].  Although some of these ORFs were confirmed to encode 
Hops [169], most of the effector proteins identified thus far, including HopPsyL, do not 
share all of the postulated characteristics.  Interestingly, HopPtoV did not share any of the 
characteristics [169], but was still shown to be secreted and translocated [169, 193].  
Identifying more P. syringae effectors does not seem to be the answer for the secretion 
signal riddle.  Instead, bioinformatic and biochemical methods such as those using 
engineered synthetic peptides [125] might aid in fully clarifying the signal.   
  
In summary, the HrpL-dependent promoter trap screen provides a relatively inexpensive, 
high throughput assay for candidate HrpL-dependent promoters that is independent of the 
role of the gene product in pathogenesis, and can be used to survey previously 
uncharacterized P. syringae strains for effector genes.  The ability to identify the set of 
effectors produced by a strain should facilitate comparative analyses of P. syringae 
strains to identify the factors controlling pathogenicity and host range.  By applying this 
screen to Psy61, we were able to isolate five effectors, including a novel locus required 




complete.  P. syringae strains are predicted to express up to 60 effectors [73].  In 
DC3000, a trial promoter trap screen led to the identification of a translocated protein 
tyrosine phosphatase that modulates several defense responses [27] and sequences 
obtained during the characterization of the promoter-active fragment carrying the shcA 
promoter facilitated characterization of the exchangeable effector loci carried by 30 P. 
syringae strains [33].  Thus, the conservation of hrpL among P. syringae strains [168] 
indicates that this assay should be broadly applicable to all P. syringae strains.     
 
Materials and Methods 
Bacterial Stains and Media.   
 
Strains and plasmids used in this study are described in Table 2-3.  Bacteria were 
routinely grown on King's medium B [12].  Plasmids were propagated in E. coli DH5α.  
E. coli strains were grown at 37ºC, and Pseudomonas syringae strains were grown at 
25ºC.  LB, MacConkey and M63 minimal salts media were used for culture of E. coli 
strains [12].  M63 medium was supplemented with 1mM MgSO4 and 1% fructose.  The 
following antibiotics were added at the indicated concentrations (in µg/ml):  ampicillin, 
200; kanamycin, 50; spectinomycin, 100, tetracycline, 25; nalidixic acid, 50; rifampicin, 
200; and chloramphenicol; 30.  L-arabinose concentration in agar media was 0.01%, 




General DNA manipulations.   
 
Restriction enzymes were purchased from Invitrogen (Bethesda, MD).  T4 DNA ligase 
was acquired from New England Biolabs (Beverly, MA) and used according to the 
manufacturer's recommendations.  Basic manipulations were done using standard 
procedures [167].  PCRs were performed using a Hybaid PCRSprint™ thermal cycler 
with 50 µl reaction volumes.  Unless indicated otherwise, Pwo polymerase (Boehringer-
Mannheim) was used to amplify fragments for cloning. 
Construction of genomic library.   
 
Genomic DNA isolations were performed following the CTAB protocol [167], and DNA 
concentration was adjusted to 1.5 µg/µl.  Genomic DNA (30 – 40 µg) was digested with 
1 unit of Sau3A for 2, 5, 10,15, and 30 min at 37ºC.  Partially digested DNA was 
fractionated by agarose gel electrophoresis, and fragments of desired sizes were isolated 
from gels using the Prep-A-Gene™ kit (Bio-Rad, Hercules, CA).  Isolated fragments 
were ligated to BamHI digested pRG970 at a molar ratio of 5:1 using T4 DNA ligase at 
4ºC.   
β-galactosidase assays.   
 





Table 2-3.  Strains, plasmids and primers used in this study. 
 
Strain or plasmid Genotype or phenotype Reference or source 
Strains   
E. coli 
  
 DH5α endA1 hsdR17 (rk- mk-) supE44 thi-1 recA1 
gyrA96 relA1 ∆(argR-lacZYA) U169 
φ80lacZDM15 
Invitrogen 
 MC4100 F' araD139 ∆(argF-lacZYA) U169 rpsL150 
relA1 flb-5301 ptsF25 deoC1 
[31] 
 SLR400 araD139 ∆(ara leu)7697 derivative of 
MC4100 
S. Benson  
P. syringae   
A9 hrpA mutant, HR- , Rifr, Kanr [194] 
DC3000 Wild-type, Rifr, HR+ 
Tomato and Arabidopsis pathogen 
[46] 
Psy61 Wild-type, Nalr , HR+ bean pathogen [15, 52] 
Psy61-2070 hopPsyA::TnphoA, Nalr, Kanr [84] 
Psy61-2074 hrpL ::TnphoA, Nalr, Kanr [84] 
Psy61-LL1 hopPsyL::pUC18K, Nal r Kanr  This work 
Plasmids   




pJBAvrRpt2-600 avrRpt2 cloned into pDSK600 [27] 
pLAFR3 IncP1, Tetr [177] 
pLL54L 1.3-kb PCR product containing hopPsyL 
cloned into pLAFR3 
This work 
pLL5446-170K 0.5-kb PCR product containing codons 46—
146 of hopPsyL cloned into pUC18K 
This work 
pLL54AvrRpt2K  This work 
pLL5446::AvrRpt2K N-terminal 46 aa of HopPsyL fused to 
‘AvrRpt2 in pDSK519 
This work 
pLL54Q30 1.2-kb PCR product containing ORF54 
cloned into pQE30 
This work 
pMLB1034 ‘lacZYA, for creating translational fusions, 
Ampr
[173] 
pMPM-K6 AraC+, PBAD –MCS, Kanr, Spr:Ω, OriVP15A [136] 
pQE30 Amr, mcs:his Qiagen 
pRG970 IncP, Spr , promotorless lacZ and gusA in 
opposite orientations 
[187] 
pSHL4K PBAD:’hrpL fusion in pMPM-K6, Kmr, 
∆Ω:Spr
[27] 
pTS54R 1.2-kb genomic fragment from Pss61 cloned 
into pRG970  
This work 























Inverse PCR.   
 
Inverse PCR was performed using the procedures of [152].   Psy61 genomic DNA (1 µg) 
was digested with SstI and self ligated.  The ligation mixture was diluted 100X and used 
as template for PCR using primers 54-739B and 54-1029 and ProofPro™ DNA 
polymerase (Continental Lab Products) following the manufacturer’s protocol. These 
primers were located 100-200 bp internal to the previously sequenced portion of ORF54, 
such that any specific amplification product could be identified by the presence of these 
known flanking sequences.  Thermal cycling was carried out using a 53°C annealing 
temperature and an extension time of 6 min.  Amplified fragments were gel purified and 
nucleotide sequence obtained at the University of Maryland Sequencing facility.    
TAIL-PCR.   
 
The Psy61 genome was used as template for TAIL-PCR following the protocols of Liu 
and Whittier [123].  Primer 54-549E was used for the primary PCR reaction with the 
degenerate primer AD3.  For the secondary and tertiary nested PCR reactions, primers 
54-739E and 54-1029 were used, respectively.  The PCR product was purified using 
Qiaquick PCR purification kit (Qiagen) and nucleotide sequence obtained at the 




Construction of Psy61-LL1.  
 
The region of hopPsyL corresponding to codons 40-170 was amplified by PCR from 
genomic Psy61 DNA using primers 54-739E and 54-1247B, digested with EcoRI and 
BamHI and ligated into pUC18K which does not replicate in Psy61.  The resulting 
plasmid was transformed into Psy61.  Nalr Kanr integrants were selected and gene 
disruption confirmed by PCR analysis and Southern hybridization. 
Construction of pLL54Q30 and size determination of HopPsyL.  
 
hopPsyL was amplified using primers 54q30S and 54-1871S, and cloned into pQE30 as a 
SmaI fragment.  To determine the size of HopPsyL, DH5α (pLL54Q30) was grown to 
OD600 0.2, IPTG was added to 2mM and HopPsyL expression was induced for 2 hr.  The 
cells were harvested and resuspended in 50 µl SDS-loading buffer.  Samples were run on 
a 12% SDS-PAGE gel, and blotted onto PVDF membranes.  The samples were probed 
using a monoclonal anti-His antibody (Novagen, WI), and visualized using a goat anti-
mouse HRP conjugate and an ECL chemiluminescence kit (Amersham-Pharmacia, NJ). 
AvrRpt2 translocation assay.   
 
AvrRpt2 translocation assays were performed as described previously [76] with minor 
changes.   The amino terminal region of hopPsyL was amplified from genomic Psy61 
DNA using primer 54-549 and reverse primer 54-Rpt246-SapI to generate a fragment 




408SapI and AvrRpt2-1028X.  These fragments were digested with SapI and ligated.  
The ligation mixture was used as a template for a PCR amplification of the fusion using 
primers 54-549X and AvrRpt2-1028X.  The resulting PCR product was extracted from 
agarose gels using the QIAspin kit (Qiagen, CA) and cloned into pDSK519 as an XbaI 
fragment. Clones with the correct orientation were transformed into DC3000 and 




A. thaliana Col-0 and P. vulgaris cv. Kentucky Wonder plants were inoculated with 105 
cfu/ml suspensions of the indicated strains unless indicated otherwise. P. vulgaris cv 
Kentucky Wonder plants were scored daily using the five point scale described 
previously [93].  Bacterial populations were monitored as described previously [18].  For 
HR phenotype in N. tabacum, A. thaliana, or P. lunatus leaves, bacteria were grown to 
109 cfu/mL in KB and serially diluted to 108, 107, and 106.  Dilutions were infiltrated into 
leaves and HR was scored after 18 hours.  The plants used were: N. tabacum cv. Samsun, 
Phaseolus lunatus cv Roma, and A. thaliana accessions Col-0, Col-0/rps2, Tsu-1, 
Leesburg, Shadhana, Ws and Dijon.  
PR1 induction assay 
 
Leaves of A. thaliana Col0:PR1/GUS plants [172] were inoculated with bacterial 




assay with the fluorogenic substrate 4-methyl-umberlliferyl-β-D-glucuronide (ICN 
Biochemicals).  Reactions were incubated 30 minutes at 37º C, and the fluorescence was 
measured using a TKO 100 fluorometer (Hoefer Scientific).  The units of activity were 
calculated using a standard curve. 
Colony Hybridizations.   
 
A 32P-labelled probe was generated by PCR amplification from Psy61 genomic DNA 
with primers 54-549E and 54-1247B in a reaction containing 25 µCi of γ -32P dATP.  P. 
syringae colonies were transferred to charged nylon membranes, lysed and allowed to 
hybridize to the labeled probe under low stringency conditions[167].  Colonies that 




Chapter 3: Type III secretion chaperones of Pseudomonas 
syringae protect effectors from Lon-mediated degradation. 
Introduction 
The array of effectors translocated by the TTSS of each pathogen is distinct [26, 39, 
45].  For plant pathogenic bacteria, effectors have been associated with the 
suppression of defense responses and enhanced nutrient leakage in susceptible plants, 
or alternatively with the activation of programmed cell death in resistant plants [26, 
48, 73, 176].  In mammalian pathogens, effectors have been shown to suppress or 
activate innate defense responses, regulate the inflammatory response and cause 
cytoskeletal rearrangements in host cells [45]. The number of effectors produced by 
pathogenic strains varies from as few as nine in Yersinia [41] to an estimated more 
than sixty for individual P. syringae strains [39, 73].   Interestingly, effectors from 
both groups of pathogens can be enzymes, such as protein tyrosine phosphatases and 
cysteine proteases [13, 27, 55, 103, 151, 154, 171], but in P. syringae strains the 
function for most has not been established. 
 
Despite the variety of effectors produced by plant and mammalian pathogens, the 
mechanism of effector secretion is thought to be similar for all TTSS.  A cryptic N-
terminal secretion signal directs effectors to the secretion port [44] [162]. Both co-
translational and post-translational mechanisms have been proposed to be involved in 




introduced and directed through the central channel of the secreton in an ATP-
dependent process [160, 197].  The size restriction of the secreton channel (~20Å) 
[21, 111] predicts that effectors are likely to be in an unfolded state during the 
secretion process. Consistent with this model, peptide structures with diameters 
greater than the ~20 – 30Å obstructed the secretion channel [60].  
 
Regulation of effector secretion is complex and involves multiple tiers as observed in 
flagellar biosynthesis [175].  In many cases, contact with a host cell activates a 
regulatory network to express the genes required for assembly of the TTSS [2, 40] 
[89].  Transcription and/or translation of these genes is thought to occur in a specific 
order to assemble the translocation apparatus similarly to the flagellar biosynthesis 
apparatus [35].  Culture conditions mimicking the host environment have been used 
to bypass the contact-dependent regulation of the TTSS of many pathogens such as 
Yersinia pestis [61] and P. syringae [188, 202].  A second tier of regulation results in 
the expression of genes whose products are substrates for type III secretion [40, 89].  
In some species, effectors do not appear to be secreted simultaneously [24, 37, 51].  
Therefore, an additional level of regulation within the second regulatory tier has also 
been proposed that establishes a hierarchy for effector secretion [24].  The exact 
manner in which the hierarchy is determined is as yet unclear, but appears to involve 
a family of proteins called TTSS chaperones [59, 156, 198].   
 
P. syringae strains express a TTSS encoded by the hrp pathogenicity island that is 




the regulatory network associated with the hrp TTSS showed that HrpR and HrpS are 
truncated enhancer binding proteins that interact to form an activation complex for 
the hrpL promoter [90].  HrpL, an alternative sigma factor, can recognize a conserved 
promoter sequence to direct the expression of all known genes encoding components 
of the hrp translocation apparatus as well as the translocated effectors and their 
cognate chaperones [62, 199, 201].  Expression of the TTSS of P. syringae is minimal 
under nutritionally-rich growth conditions, but is activated in planta or under 
conditions that mimic the host environment, such as acidic minimal salts media (i.e. 
inducing conditions) [202].  During a search for a postulated negative regulator of the 
hrp TTSS, Lon protease was shown to mediate the turnover of HrpR to regulate 
expression of hrpL [25].  Regulated proteolysis by Lon functions in several regulatory 
networks in eubacteria, and Lon has also been associated with the degradation of 
abnormally folded proteins [70].  Interestingly, lon mutants of P. syringae exhibited 
substantially higher protein secretion and induced plant defense responses faster than 
the wild type strain [25].  Ectopic expression of HrpRS by several groups, however, 
has not reproduced this phenotype, suggesting that Lon could have an additional role 
in the regulation of type III secretion in P. syringae strains. 
 
Here we report that Lon-mediated regulation of the P. syringae TTSS also involves 
regulated proteolysis of effectors prior to secretion that can be suppressed by the 
cognate chaperone.  Domains targeting effectors for degradation were identified.  The 
data advances our understanding of the essential role of chaperones in protecting 




hierarchical secretion of effectors.   
 
Results 
P. syringae lon mutants hypersecrete the TTSS-dependent effector AvrPto 
During the initial studies, other members of the lab noticed lon mutants could elicit 
the early visible symptoms of the HR more rapidly than wild-type P. syringae.  
Additionally, the mutants secreted higher amounts of specific proteins into cell 
supernatants.  The data suggested that these mutants were specifically secreting 
higher amounts of effectors.   To determine if the lon::Tn mutants could secrete 
effectors in the absence of plant host, avrPto was ectopically expressed using a 
vector’s Plac promoter and secretion of AvrPto into culture filtrates was monitored. As 
reported previously [188], secretion of AvrPto by the wild-type P. syringae was 
difficult to detect.  Levels of AvrPto in immunoblots of concentrated culture filtrates 
from Psy61 (pAVRPTO6H-600) were nearly undetectable (Figure 3-1). Culture 
filtrates of the lon::Tn mutant KL11 (pAVRPTO6H-600), however, were estimated to 
contain at least 100-fold higher levels of AvrPto than its Lon+ parent strain after 
densitometry analysis. 
Secretion through the hrp TTSS is regulated beyond HrpL 
To determine whether the role of Lon in the regulation of the hrp TTSS is limited to 
the control of hrpL expression, we attempted to bypass the known regulatory activity 




Figure  3-1. Secretion of AvrPto from P. syringae lon mutants.  
Levels of AvrPto were monitored in Psy61, Psy61-KL11 (lon::Tn) and a TTSS 
secretion mutant, Psy61-2082 (hrcN::Tn) expressing AvrPto from pAvrPto6H-600 
(+), or the empty vector pDSK600 (-). Overnight cultures were diluted in fresh rich 
media and grown to an OD600 of 1.0.  The cells were collected, washed and 
resuspended in hrp-inducing media (M63Fructose, pH 5.5) at an OD600 of 0.6 and 
grown for an additional 4 hours.  The cells from a 250 µL sample of the culture were 
collected and resuspended in SDS-PAGE loading buffer.  Culture filtrates of the 
remaining culture were obtained by centrifugation and concentrated 50X using 
MilliPore Ultra-free centrifugal filter devices. Ten µg of protein were loaded and 
separated in an SDS-PAGE and levels of anti-AvrPto reactive proteins monitored in 
cell lysates (A) and culture filtrates (B) using immunoblots. AvrPto migrated as an 


















expression, then vector-directed expression of hrpL should result in the same 
phenotype as a ∆lon mutant.  The induction of effector-dependent programmed cell 
death in resistant hosts and the secretion of effectors into culture supernatants was 
studied in wild-type and Lon- strains carrying a hrpL construct expressed from the 
lacUV5 promoter of pDSK600 (pMLL600).  A similar construct expressing the 
lacZYA operon (pLLlac600) exhibited equal activities in both strains.  The steady 
state level of LacZ activity in P.  syringae pv tomato DC3000 (pLLlac600) was 
346±12 Miller units whereas 375±34 units were measured in the DC3000 lon::Tn 
mutant JB7 (pLLlac600).  This similarity indicates that this expression system is 
insensitive to the activity of Lon.  Concentrated culture supernatants of DC3000 
(wild-type), JB7, or the DC3000 hrpA::kan mutant A9 carrying pMLL600 were 
monitored for AvrPto secretion using immunoblots.  As before (Figure 3-1), secretion 
of AvrPto could be detected at low levels in culture filtrates of DC3000, but up to 50-
fold higher levels were detected by densitometry in culture filtrates of the JB7 lon 
mutant (Figure 3-2).  Ectopic expression of HrpL, however, did not affect AvrPto 
secretion from the wild-type cells or the lon null mutant as levels of AvrPto in culture 
filtrates of strains carrying a HrpL expression system were indistinguishable from 
their counterparts lacking the HrpL construct.  Similarly, ectopic expression of HrpL 
did not affect the development of the HR in leaves of Nicotiana tabacum  (Table 3-1) 
whereas the Lon mutant elicited a more rapid HR as reported previously [25].  The 
observation that ectopic expression of HrpL could not bypass the Lon-mediated 
repression of the hrp TTSS activity implied that Lon has a second activity in the 




Figure 3-2.  Ectopic expression of hrpL does not bypass Lon regulation on the 
hrp cluster. 
Levels of AvrPto were monitored in culture filtrates of DC3000 (wild-type), JB7 
(lon::Tn) and a secretion mutant, A9 (hrpA::Tn) expressing hrpL from pMLL600, or 
carrying the empty vector pDSK600.  Overnight cultures were diluted into M63 
Fructose with 1% casein hydrolysate and grown to an OD600 of 1.0.  The cells were 
collected and washed in M63Fructose and diluted to an OD600 of 0.6 in hrp-inductive 
media (M63Fructose, pH 5.5) and grown for 6 hours.  The supernatants were 
concentrated 50X in centrifugal devices and ten µg of total protein from each sample 
were fractionated by electrophoresis in a 12% SDS-polyacrylamide gel.   Levels of 
anti-AvrPto reactive proteins were monitored using immunoblots.  AvrPto migrated 
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2 nr nr 
4 nr nr 
6 nr nr 
14 ++ ++ 
16 ++ ++ 
18 +++ +++ 
20 +++ +++ 
22 +++ +++ 
24 ++++ ++++ 
 
1. Leaves of Nicotiana tabacum cv. Samsun were inoculated with a 108 cfu/ml 
suspension of DC3000 (empty vector) or DC3000 (pMLL600 expressing 
HrpL).  The induced HR was measured every 2 hours for water soaking as 
evidence of initiation of HR, and then for tissue collapse and necrosis.  
2. The symptoms were scored using the following scale:  nr, no reaction; ++, 




P. syringae effectors are subject to Lon degradation 
The role of Lon in the proteolysis of abnormally folded proteins [70] raised the 
possibility that Lon could directly target AvrPto and other TTSS effectors for 
degradation, since they are predicted to be in an unfolded state prior to secretion [60, 
179].  The stability of AvrPto was compared in DC3000 (pMLAvrPto600) and JB7 
(pMLAvrPto600) expressing AvrPto from the Lon-insensitive pDSK600 expression 
system described above. The amounts of AvrPto after inhibition of translation were 
measured by probing whole-cell extracts with anti-AvrPto sera.  The stability of 
AvrPto in translationally inhibited cells appeared to be substantially higher in the lon 
mutant.  The estimated half-life of AvrPto was 8 min in DC3000, but was greater than 
30 min in JB7 (Figure 3-3).  Notable differences in the initial levels of AvrPto were 
detected between Lon+ and Lon- strains.  Roughly five times more AvrPto could be 
detected in JB7 when compared to DC3000 (Figure 3-3).  Since the rate of synthesis 
would be expected to be equivalent in the two strains, the difference in accumulation 
of AvrPto is likely attributable to faster degradation of AvrPto in the presence of Lon.  
In contrast, the levels of a similarly expressed bacterial alkaline phosphatase (BAP-
FLAG) were indistinguishable between the two strains (Figure 3-3) and the half-life 
of BAP-FLAG was found to be greater than 30 minutes in either DC3000 or JB7 
(Figure 3-3). 
 
To assess whether other effectors might also be targets for Lon-mediated degradation, 




Figure 3-3.  Effect of Lon protease on stability of effectors in P. syringae. 
Levels of AvrPto, HopPsyA, AvrRpt2 and BAP-FLAG detected in immunoblots.  
Overnight cultures of DC3000 (wild-type) or JB7 (lon::Tn) ectopically expressing the 
effectors were diluted into M63 fructose media and grown at 25º C to an OD600 of 0.6.  
Translation was stopped by the addition of tetracycline to a final concentration of 200 
µg/ml, and 250 µl samples were taken at the times (min) indicated above.  The cells 
were collected by centrifugation and resuspended in 50 µl of SDS-PAGE loading 
buffer to lyse the cells.  Whole-cell lysates were separated in a 12% SDS-PAGE, and 
immunoprobed with anti-AvrPto, anti-AvrRpt2, anti-HopPsyA or anti-FLAG sera.  
Levels of effectors were estimated in scanned images using NIH Image 1.59 and 
normalized to total cells.  The abundance of effectors (DC3000, open circles; JB7, 
closed squares) was calculated relative to their initial amounts at time 0 min.  
Estimated levels from single experiment are shown, but similar results were obtained 
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conditions known to enhance expression of effectors.  Using polyclonal antibodies 
raised against the purified polypeptides (gifts of S. Heu, and J. Greenberg, 
respectively), HopPsyA from Psy61 and AvrRpt2 from P. syringae pv. maculicola 
ES4326 were also found to be unstable in Lon+ P. syringae cells.  As with AvrPto, 
the initial levels of both HopPsyA and AvrRpt2 appeared to be 2-5 times higher in the 
Lon- mutants than in wild type strains (Figure 3-3) and the observed half-lives of both 
effectors were considerably longer in the lon null mutant.  HopPsyA exhibited an 
apparent half-life of 6 min in the wild-type strains that increased to >30 min in the 
∆lon mutant.  Similarly, the half-life of AvrRpt2 increased 3-fold in the ∆lon mutant.  
Lon modulates hrp TTSS in an E. coli background. 
Previous studies had shown that E. coli MC4100 expressing a the hrp cluster carried 
by pHIR11 could elicit effector-dependent responses in tobacco leaves [85], and 
therefore, assemble a functional TTSS [6].  Because a P. syringae lon allele could 
complement a mutation in its E. coli counterpart [25], inactivation of lon in E. coli 
should modulate effector levels and stability similarly to that observed in P. syringae.  
The MC4100 derivatives SG22622 (wt) and SG22623 (∆lon) were transformed with 
pHIR11 and their ability to elicit an effector-dependent response in tobacco plants 
was tested.  As observed in P. syringae, Lon- SG22623(pHIR11) elicited a visible 
programmed cell death response in 14 hrs, whereas Lon+ SG22622(pHIR11) took 
over 30 hrs to produce a similar response (Figure 3-4).  These results suggest that the 




Figure 3-4.  E. coli ∆lon mutants induce HR in half the time as wild-type. 
Overnight cultures of E. coli SG22622 (wild-type) and SG22623 (∆lon) carrying 
pHIR11 (cosmid clone expressing a functional hrp cluster) were diluted in M63 
Fructose with 1% casein hydrolysate and grown at 37 °C to an OD600 of 1.0.  The 
cells were collected and washed with fresh media, and resuspended to 109 cfu/ml. 
Nicotiana tabacum cv Samsun leaves were infiltrated with roughly 100 µl of the 
suspension and scored for visible signs of a hypersensitive response (HR) during the 
first 30 h.  Note that lon mutants could induce the HR as indicated by water soaking 
and tissue collapse by 14 h (highlighted area), whereas wild-type required greater 
















To determine if inactivation of lon also caused enhanced secretion of effectors from 
the E. coli transformants, levels of ectopically-expressed AvrPto, AvrRpt2 and 
HopPsyA were monitored in culture filtrates.  The effectors could be detected at low 
levels in culture filtrates of Lon+ SG22622 (pHIR11) transformants (Figure 3-5).  
AvrPto, AvrRpt2 and HopPsyA, however, were detected in culture filtrates of the 
Lon- SG22623 (pHIR11) and were not obvious in culture filtrates of SG22623 
(pLAFR3), a vector control. These results suggest that the role of Lon in the 
regulation of effector secretion is similar in the E. coli and P. syringae systems.  
 
Lon affects stability of effectors in E. coli 
 
To assess whether Lon plays a role in the stability of effectors in E. coli, the half-lives 
of AvrPto, HopPsyA, and AvrRpt2 were determined in translationally-inhibited Lon+ 
SG22622 and Lon- SG22623 as before.  For all three of these effectors, a 2- to 5- fold 
increase in their observed half-life was detected in the lon null mutant as observed in 
P. syringae  (Figure 3-6).  However, similar to what occurred in P. syringae, the 
initial amounts of the polypeptides were significantly lower in the wild-type than the 
lon mutant cells. The abundance of effectors in the wild-type cells was between 20 
and 40% of that observed in the ∆lon cells (Figure 3-6).   
 
To determine if the stability of effectors from other P. syringae strains was also 




Figure 3-5.  P. syringae effectors are secreted from an E. coli lon background 
 
Levels of effectors secreted from E. coli in immunoblots.  AvrPto, HopPsyA, and 
AvrRpt2 were ectopically expressed from pDSK600, pYXSS or pDSK519 in E. coli 
SG22622 (wild-type) or SG22623 (∆lon) carrying either pLAFR3 or pHIR11 
expressing a functional hrp TTSS.  Overnight cultures were diluted into M63 
Fructose with 1% casein and cells were grown 5 h at 37ºC.  The supernatants were 
concentrated as in Figure 3-1 and protein levels determined using the micrBSA 
protein assay kit (Pierce, Ca).  Ten µg of total protein were loaded and separated in an 
12% SDS-PAGE and anti-AvrPto, anti-HopPsyA or anti-AvrRpt2 reactive proteins 
were monitored using immunoblots. AvrPto migrated at 18 kDa, HopPsyA migrated 




 -hrp +hrp 
 








Figure 3-6.  Lon affects the stability of P. syringae effectors in E. coli. 
E. coli SG22622 (WT) or SG22623 (Lon-) carrying AvrPto, AvrRpt2 or HopPsyA 
expressed as in Figure 3-3, and HopPtoG, or HopPsyE expressed from pTrcHis2 were 
grown to an OD600 of 0.6 and translation was stopped by the addition of excess 
chloramphenicol (200 µg ml-1).  Whole cell lysates were treated as in Figure 3-3, and 
the levels of effectors were monitored in immunoblots using NIH Image 1.59.  The 
half lives were estimated in immunoblots using appropriate polyclonal or anti-His 
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syringae pv syringae DH015 were cloned into pTrcHis2 to generate a C-terminal 
6xHis epitope tag and the stability of each fusion was monitored in SG22622 and 
SG22623 using anti-His antibodies.  A comparison between the half-life of native 
AvrPto and 6xHis-tagged AvrPto in P. syringae showed that the fusion did not alter 
the stability of AvrPto (8.5 vs. 9 min, respectively).  In all cases, the measured 
stability of the epitope-tagged effector was 2-4-fold higher in ∆lon mutants (Figure 3-
6).  These results suggest that effectors are generally susceptible to degradation by 
Lon prior to secretion, irrespective of the source and host strain.  The effectors 
appeared to fall into two general categories of stability: effectors had half-lives 
shorter than 2 minutes, and those with half-lives of >6 minutes (Figure 3-6).   
Chaperones stabilize effectors 
To investigate the effect of chaperones on the stability of P. syringae effectors, the 
half-lives of HopPsyB1, HopPtoM and HopPsyV1 were determined in Lon+ SG22622 
or Lon- SG22623 in the presence or absence of their cognate chaperones, ShcB1, 
ShcM, and ShcV1, respectively. Each chaperone was cloned individually into 
pDSK519 such that expression was directed from the lac promoter and the construct 
was transformed into the E. coli strains carrying one of the previously mentioned 
effector constructs.  In each case, the co-expression of the chaperone had a stabilizing 
effect on its cognate effector as expected.  The t½ of HopPsyB1 increased from under 
1 min in SG22622 (pLLhopB1-Trc)(pDSK519) to 5 min in SG22622 (pLLhopB1-
Trc)(pLLshcB-1D) (Figure 3-7).  This effect was only observed in Lon+ SG22622.  




Figure 3-7.  Effectors are stabilized by their chaperone. 
Estimation of half-lives of effectors in the presence of chaperones.  Overnight 
cultures of E. coli ectopically expressing HopPsyB1, HopPsyV1, or HopPtoM 
carrying their cognate chaperone (Chap) or empty vector in SG22622(WT) or 
SG22623 (Lon) were diluted and grown in LB at 37ºC until they reached an OD600 of 
0.6 and the half life of each effector was estimated as in Figure 3-3.  The results are 
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ShcV1 increased the half-life of HopPsyV1 to >30 min which is comparable to its t0.5 
in Lon- SG22623.  Likewise, the half-life of HopPtoM increased from 5 min in the 
absence of its chaperone to >20 minutes when ShcM was expressed (Figure 3-7).  
The effects of these chaperones were specific, as expression of a heterologous 
chaperone did not affect the stability of the effectors HopPsyB1 or HopPsyV1 (Figure 
3-7).  The results suggest that a primary role for chaperones in TTSS could be 
protection of effectors from Lon-mediated degradation.   
The Lon-Targeting Domain of HopPtoM Does Not Overlap Its Chaperone-
Binding Domain 
The manner in which chaperones protect effectors from degradation is unknown.  
Other Lon-degraded proteins, such as SulA and UmuD, are targeted to Lon by 
specific amino or carboxy terminal motifs [68, 95].  It is possible that a TTSS 
chaperone protects its cognate effector by masking a Lon-targeting motif.  
Alternatively, the chaperone could be directly inhibiting Lon activity or forming a 
complex with the effector that is immune to degradation.  To test the possibility that 
the chaperone directly inhibits Lon, the activity of RcsA was monitored in strains 
expressing the chaperones ShcB1, ShcV1 or ShcM from pDSK519.  RcsA is a 
transcriptional activator that regulates the expression of cpsB, and whose activity is 
regulated by Lon [72].  A chromosomal cpsB::lacZ reporter that is only expressed 
when RcsA is not degraded by Lon was used to monitor Lon activity.  Consistent 
with the specificity of activity for the chaperones, none of the chaperones had an 




not generally inhibit Lon activity.   
 
The apparent chaperone-binding domain (CBD) of HopPtoM had previously been 
localized to an internal 300 aa domain located between residues 100-400 [14]. To 
determine if the Lon-targeting domain of HopPtoM overlaps this apparent CBD, His-
tagged derivatives of HopPtoM were created that carried either amino or carboxy 
terminal deletions that mirrored those used in the previous analyses (Figure 3-8a).  
One of the constructs (∆400) contained the fragment encoding the polypeptide 
domains that did not interact with ShcM, whereas the other two constructs (∆200 and 
N200) contained coding sequence for regions that did interact [14].  When the 
constructs were expressed in Lon+ cells, the constructs expressing the C-terminus of 
the peptide were degraded (Figure 3-8b).  Among these, the ∆400 truncation lacking 
any of the CBD exhibited a short half-life (3 min).  In contrast, the construct that 
expressed only the N-terminus, N200, which includes a portion of the  CBD, was not 
degraded by Lon as the half-lives were equal in both strains (>30 min)(Figure 3-8b).  
These results suggest that the Lon-targeting domain of HopPtoM is located in the C-
terminal 312 amino acids, and does not overlap with the CBD. 
 
To verify that the C-terminus of HopPtoM could target the peptide for Lon-mediated 
degradation, a fusion between HopPtoM∆400 and the maltose binding protein (MBP) 
was constructed and tested for sensitivity to Lon.  MBP has previously been shown to 




Figure 3-8.  The C-terminus of HopPtoM targets the peptide for degradation. 
A.  Schematic diagram of HopPtoM truncations used in this study.  CBD, chaperone 
binding domain.  B. N-terminal truncations lacking the first 200 or 400 amino acids 
(HopPtoM∆200, and HopPtoM∆400, respectively) or a C-terminal truncation expressing 
only the first 200 amino acids (HopPtoM200) were expressed in SG22622 (WT) and 
SG22623 (Lon) or SG22622 carrying pShcMD (Chap).  The half lives of each 
derivative were estimated as in Figure 3-3 using polyclonal antibodies raised against 
HopPtoM.   Equivalent results were obtained in three different experiments.  The 
reduced levels of HopPtoM∆400 observed in the 8 minute sample from the lon mutant 
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the Lon-targeting motif in SulA [95].  A MBP:LacZ fusion was expressed in 
SG22622 and SG22623 and its half-life determined to be roughly 35 minutes in both 
backgrounds (Figure 3-9).  In contrast, when HopPtoM∆400 was fused to MBP, it was 
degraded in the wild type background with a half-life of 8.5 min (Figure 3-9).  This 
construct was only slowly degraded in the ∆lon mutant background as its half-life 
was 24 minutes.  Taken together these results support the hypothesis that the Lon-
targeting domain of HopPtoM is located in the C-terminus, and that it is sufficient to 
target polypeptides for Lon-mediated degradation.   
 
Discussion 
Lon has been previously shown to regulate assembly of the hrp-encoded TTSS in P. 
syringae strains through its effects on the activity of the hrpL promoter [25]. 
Regulated proteolysis of the transcriptional activator HrpR controlled the activity of 
the hrpL promoter, thereby modulating expression of the Hrp regulon.  Interestingly, 
the lon mutants also secreted several effectors consistent with a TTS+ phenotype that 
could not be reproduced by ectopic expression of hrpRS or hrpL.  This suggested that 
Lon had an additional activity in the regulation of hrp TTSS.  Consistent with this 
hypothesis, eight distinct effectors isolated from several P. syringae strains were 
found to be unstable in Lon+ P. syringae and E. coli strains, but were relatively stable 
in the corresponding Lon- mutants.  Targeting domains for Lon-mediated degradation 




Figure 3-9.  An MBP fusion to the C-terminus of HopPtoM is degraded. 
A The ∆400 or N200 truncations of HopPtoM (Figure 3-8) were amplified by PCR 
using specific primers and used to create fusions with the C-terminus of MBP in the 
vector pMAL-p2x (New England Biolabs) following manufacturer’s instructions.  
Cells expressing any of MBP::LacZ or the fusion proteins were induced for 2.5 h and 
translation was stopped using cholarmphenicol (200 µg/mL) and levels of the fusions 
estimated in 250 µl samples at the indicated times.  The relative amounts of the fusion 
proteins were monitored in immunoblots using anti-MBP antibodies, and the half 
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 the degradation of the cognate effector in Lon+ cells.  Thus it appears that Lon has a 
dual function in the regulation of the hrp TTSS of P. syringae strains by: 1) 
regulating the assembly of the TTSS and expression of effectors through regulated 
proteolysis of HrpR [25]; and 2) controlling the accumulation of effectors prior to 
secretion through turnover.   
 
Lon belongs to a family of cytosolic ATP-dependent proteases that are highly 
conserved among prokaryotes and Archea and are also found in eukaryotic organelles 
(reviewed in [195]).  Like other bacterial energy-dependent proteases, Lon forms a 
multimeric complex that couples ATP-dependent protein unfolding with an 
endopeptidase activity [190] [195] to rapidly degrade targeted proteins.  Each of these 
activities is assigned to independent domains separated by a “sensor and substrate-
discrimination” domain (SSD) which functions in substrate selection.  Each of the 
functional domains is conserved in the P. syringae Lon homolog and the P. syringae 
Lon can complement its E. coli counterpart [25].  P. syringae lon::Tn mutants 
exhibited enhanced cell length and UV sensitivity similar to Lon null mutants of other 
bacteria.  Thus, P. syringae Lon likely functions similarly to its homologs of other 
bacteria.   
 
Lon is well known for its involvement in the degradation of unstable regulatory 
proteins, such as FlhC/FlhD, SulA and RcsA/RcsB [36, 71, 181].  Another principal 
activity of Lon is the degradation of misfolded or abnormal proteins, such as those 




mutations [70].  Because TTSS-linked effectors are predicted to be in an unfolded 
state prior to secretion [59, 156, 179], they would be strong candidates for 
degradation by proteases such as Lon.  Among the effectors studied, five had 
apparent half-lives of less than 2 min in Lon+ strains whereas three others had 
apparent half-lives longer than 6 min.  Consistent with the observed degradation rates, 
steady state levels of effectors expressed from a lacUV5 promoter were 20 to 50% of 
the levels detected in Lon- mutants.  Since levels of LacZ expressed from the same 
promoter were indistinguishable between Lon+ and Lon- cells, the rate of synthesis 
for these ectopically-expressed effectors is likely to be equivalent in Lon+ and Lon- 
cells.  The differences in the steady state levels, thus, are consistent with the observed 
differences in the rate of decay.  The instability of the tested effectors in Lon+ P. 
syringae and E. coli cells and the absence of proteolytic degradation products in 
immunoblots suggest the direct degradation of effectors by Lon.   
 
TTSS chaperones are usually small acidic proteins that can interact with one or more 
effectors.  In the absence of their cognate chaperones, some effectors are not readily 
secreted, and consequently chaperones have been proposed to act either as secretion 
pilots or as factors that maintain effectors in a “secretion-competent” state [59, 156].  
For example, the crystal structure of the Salmonella effector SptP interacting with its 
chaperone SycP revealed that SptP was maintained in an “unfolded” state in which 
the effector is wrapped around the chaperone [179].  A similar structure was resolved 
for the YopE-SycE complex [20].   Another proposed role of chaperones has been to 




example, binding of the chaperone SycD neutralizes the intracellular toxicity of YopB 
when expressed in E. coli [150].  More recently, chaperones have been proposed to 
control the timing of effector secretion as mentioned above.  This activity was first 
identified for SicA, the Salmonella chaperone for SopA, which interacts with the 
TTSS transcriptional activator InvF to promote the expression of virulence factors 
[186].  In addition, other chaperones, such as FlgN, can control the expression of 
class III flagellar genes by activating the secretion of FlgM [105].  The Yersinia 
chaperone SycD/LcrH can interact with YopD to regulate the expression of YopQ 
[8], and IpgC, the chaperone for IpaB and IpaC, can bind to MxiE and activate the 
transcription of at least two effectors in Shigella [135]. 
 
Our results are consistent with other studies proposing that chaperones act as 
stabilizing agents for their effectors.  In Yersinia and Salmonella strains, cytoplasmic 
levels of some effectors have been higher in the presence of their cognate chaperone 
consistent with protection from proteolytic degradation [63, 64].   Lon-mediated 
degradation of the tested effectors could be suppressed by the cognate chaperone.  
The effect was specific to a chaperone-effector interaction as only the cognate 
chaperone stabilized the effector.  It is likely, then, that one of the major roles for 
chaperones is in fact to protect effectors from Lon-mediated degradation.  Consistent 
with this hypothesis, the chaperones had little effect on the half-lives of effectors in 
strains lacking Lon.  In contrast to many effectors of mammalian pathogens, most 
effectors expressed by P. syringae strains do not have an obvious cognate chaperone.  




with a chaperone.  Why some effectors have a chaperone, and most do not is an 
enigma.   
 
The mechanism by which P. syringae chaperones protect effectors from Lon-
mediated degradation does not appear to be due to the masking of the targeting motif 
in the case of HopPtoM.  ShcM has been reported to interact with an internal domain 
of HopPtoM located between residues 100-300 [14] whereas the Lon-targeting 
domain in HopPtoM was shown here to be located in the carboxy terminal domain 
and does not overlap with the previously established chaperone binding domain.  
Most likely, this chaperone-effector complex has a Lon-insensitive conformation.  
Crystal structures of other chaperone-effector interactions have revealed a high 
degree of secondary structure [19, 57, 179].  Since unfolding of the substrate is an 
essential part of Lon proteolysis [190], the formation of a stable complex structure 
with the chaperone would inhibit its degradation by Lon.  
 
It is becoming increasingly clear that, at least in mammalian pathogens, chaperones 
play a crucial role in determining the hierarchy of effector secretion [59, 156, 198].  
Whether the chaperones in P. syringae also have a similar role is an interesting 
question.  Differential degradation of effectors prior to secretion, however, could 
provide a mechanism for controlling the hierarchy of effector secretion.  Since 
suppression of proteolysis through inactivation of Lon increased the secretion of 
effectors from the hrp TTS, it appears that proteolytic degradation of effector 




system itself [22] can not be completely excluded).  Effectors with longer half-lives 
are likely to be secreted at higher levels than those with short half-lives and would 
accumulate more rapidly in host cells.   
 
In conclusion, we found that Lon plays an important role not only in the regulation of 
assembly of the TTSS, but also in controlling the secretion of effectors through that 
system.  The impact of Lon on effector stability may not be unique to P. syringae 
effectors.  A stabilizing effect of chaperones has been reported in other systems [63] 
[34] [64].  YopE and SptP, for example, are readily detectable in the presence of their 
corresponding chaperones, SycE and SicP respectively, but only a small percentage 
of that amount is present in the absence of the chaperone [34] [64].  The mechanism 
for effector degradation and chaperone stabilization has not been established in these 
systems but seems likely to be due to Lon-mediated degradation.  Lon has been 
shown to influence the assembly and activity of the SPI TTSS of Salmonella [22, 
182].  Here we propose a model in which effectors would have two distinct fates in 
the bacterial cell:  secretion through the TTSS, or degradation by Lon that is most 
consistent with the post-translational mechanism for secretion of effectors by the 
TTSS.  Differential turnover of effectors could provide a mechanism for the 





Materials and Methods 
Bacterial Stains and Media.   
Strains and plasmids used in this study are described in Table 3-2.  Bacteria were 
routinely grown on King's B medium [12].  Plasmids were propagated in E. coli 
DH5α.  E. coli strains were grown at 37ºC, and Pseudomonas syringae strains were 
grown at 25ºC.  LB and M63 minimal salts media were used as described previously 
[167].  M63 medium was supplemented with 1mM MgSO4 and 1% fructose (M63F).  
The following antibiotics were added where needed at the indicated concentrations 
(in micrograms per milliliter):  ampicillin, 200; kanamycin, 50; spectinomycin, 100, 
tetracycline, 25; nalidixic acid, 50; rifampicin, 200; and chloramphenicol; 30. 
General DNA manipulations.   
Restriction enzymes were purchased from Invitrogen (Bethesda, MD).  T4 DNA 
ligase was acquired from New England Biolabs (Beverly, MA) and used according to 
the manufacturer's recommendations.  Basic manipulations were done using standard 
procedures.  PCRs were performed using a PCRSprint thermal cycler (Hybaid, 
Ashford, UK) with 50 µl reaction volumes.  Unless indicated otherwise, ProofPro 





Table 3-2.  Strains, plasmids and primers used in this study. 
Strain or plasmid Genotype or phenotype Reference or 
source 
Strains   
E. coli   
 DH5α endA1 hsdR17 (rk- mk-) supE44 thi-1 recA1 
gyrA96 relA1 ∆(argR-lacZYA) 
U169φ80dlacZDM15 
Invitrogen 
SG22622 cpsB::lacZ ∆ara malP::lacIq S. Gottesman 
SG22623 SG22622 ∆lon-510 S. Gottesman 
SLR400 araD139 ∆(ara leu)7697 derivative of 
MC4100 
S. Benson 
 TOP10 F- mcrA (mrr-hsdRMS-mcrBC) 80lacZ
M15 lacX74 recA1 ara 139 (ara-
leu)7697 galU galK rpsL (StrR) endA1 
nupG 
Invitrogen 
Pseudomonas syringae  
A9 DC3000 hrpA mutant, HR- , Rifr, Kanr [194] 
DC3000 Wild-type, Rifr, HR+ 
Tomato and Arabidopsis pathogen 
[46] 




Psy61 Wild-type, Nalr , HR+ 
Weak bean pathogen 
[15] 
Psy61-KL11 Nal r Kanr , lon::Tn [25] 
Plasmids   
pAvrRpt2D 1.0 kb PCR product containing avrRpt2 
cloned into pDSK519 
This work 
pDSK519 Broad-host range vector, IncQ Kanr [107] 
pDSK600 Broad-host range vector, IncQ Spr [147] 
pFLAG-CTS-BAP Bacterial Alkaline Phosphatase in pFLAG-
CTC 
Sigma-Aldrich 
pHIR11 pLAFR3 derivative carrying P. syringae pv. 
syringae 61 hrp/hrc cluster, Tcr
[85] 
pHopPsyB1trc hopPsyB1 cloned into pTrcHis2 This work 
pHopPsyEtrc hopPsyE cloned into pTrcHis2 This work 
pHopPtoGtrc hopPtoG cloned into pTrcHis2 This work 
pHopPtoMtrc hopPtoM cloned into pTrcHis2 This work 
pHopPtoM∆400trc C-terminal 1836 bp of hopPtoM cloned into 
pTrcHis2 
This work 
pHopPtoM∆200trc C-terminal 1536 bp of hopPtoM cloned into 
pTrcHis2 
This work 






pHopPtoM∆400MAL MBP fusion to the C-terminal 1836 bp of 
hopPtoM in pMAL-p2x 
This work 
pHopPsyV1trc hopPsyV1 cloned into pTrcHis2 This work 
pLAFR3 Tcr, IncP1  [177]  
pLLlac600 HindIII-PstI fragment from pRG970, 
subcloned into pDSK519 and then the Lac 
operon excised with EcoRI and cloned into 
pDSK600 , Spr, Lac+  
This work 
pMAL-p2x MBP::lacZ fusion New England 
Biolabs 
pMLAvrPto600 0.45 kb PCR cloned  as EcoR1-HindIII into 
pDSK600 
[25] 
pMLL600 0.4-kb PCR product containing hrpL  
cloned into pDSK600 
This work 
pSGAS 3.6-kb fragment containing hopPsyA in 
pYXSS 
[80] 
pSHAMB hopPsyA cloned into pMLB1034 [80] 
pShcB1D 0.5 kb PCR product cloned into pDSK519 This work 
pShcMD 0.5 kb PCR product cloned into pDSK519 This work 




Construction of 6xHis protein fusions.   
The genes for individual effectors were amplified from chromosomal DNA from the 
indicated strain using the following primers: hopPsyB1( Psy B5) 
ATGAACCCGATACAAACG;TTCCAACCTGAATGCCGG, hopPtoM (Pto 
DC3000) ATGATCAGTTCGCGGATC;  ACGCGGGTCAAGCAAGCC, hopPsyE1 
(Psy W4N15) ATGAGACCTGTCGGTGGG; GACCTTATAAGACAGGAC , 
hopPsyV1 (Psy B728a) ATGAATATCTCAGGTCCG; 
AGGCTTGGCCCGGACCCT, and hopPtoG (Pto DH015) 
ATGAGACCCGTCGGTGGA; ATCAGCGCCAACAATCGG, The products were 
cloned into pTrcHis2 using the TOPO TA cloning kit (Invitrogen, Carlsbad) 
following manufactures instructions.  The fusion was verified by sequencing and by 
immunodetection as described by the manufacturer. 
Cloning of effector chaperones.   
shcPsyB1 and shcPsyV1 were amplified from genomic DNA using the following 
primers:  ; GCTCTAGACAGTTCGGGATTGACAGG; 
CGGAATTCCGACAGACGCTGGAATACGG; and 
CTCTAGAACTGGACATGACGCTGGA;  
GCTCTAGAATCGAATAGTCCCCGCCA, respectively.  The PCR products were 
cloned into pDSK519 a XbaI or BamHI fragments.  shcPtoM was cloned into 
pTrcHis2 using the primers ATGACCAACAATGACCAG and 





GCTCTAGAGATTTAATCTGTATCAGG  to clone into pDSK519 or pBAD33 as 
an XbaI fragment.  Inserts were verified by restriction analysis and sequencing. 
Cloning of HopPtoM truncations.    
N-terminal truncations of HopPtoM were amplified using the forward primers M∆25 
CAGCACGATACTGTTCCC, M∆200 GCCGGTCGTGCAAGCAAG, M∆400 
CTGAAAAGCGAACACGGT, and the reverse primer 
ACGCGGGTCAAGCAAGCC.  C-terminal truncations were generated using the 
forward primer ATGATCAGTTCGCGGATC, and the reverse primers M100aa 
ACTACCGATCAACAAGCG, and M200aa GTATTCGCCAAGGGCAGT.  All 
amplification products were cloned into pTrcHis2 and inserts were verified by 
sequencing and by immunodetection following manufacturer’s directions. 
Maltose binding protein (MBP) fusions.   
The 3’ 936 bp of hopPtoM were amplified using the primers 
GCTCTAGATTAACGCGGGTCAAGCAA and 
GCTCTAGAAAAAGCGAACACGGTGAG, digested with XbaI and ligated to 
pMAL-p2x (New England Biolabs, Beverly MA) to create a C-terminal fusion to 
MBP following manufacturer’s instructions.  The 5’ 150 bp, and the 3’ XX bp of 
hopPsyB1 were amplified using the primers 
GCTCTAGATTCCAACCTGAATGCCGG; 
GCTCTAGACCGCAGGACAGGACAAGC, digested with XbaI and cloned into 




β-galactosidase assays.  
β-galactosidase activity in bacterial cells was estimated by the procedures of Miller 
[139]. 
Plant assays.   
P. syringae DC3000, JB7 and A9 were transformed with pMLL600 or pDSK600.  
Overnight cultures grown at 25 C were harvested and diluted in M63 minimal media.   
Nicotiana tabacum cv Samsun leaves were syringe infiltrated with a 108 cfu/ml 
solution of the different strains as described previously [85].  Infiltrated leaf panels 
were scored for responses beginning 2 h after inoculation and monitored for 24 h.  
For E. coli, SG22622 and SG22623 were transformed with pHIR11, pHIR11-2082, or 
pLAFR3 and used to inoculate N. tabacum plants in the same way as P. syringae. 
Secretion of effectors from bacterial cultures. 
Culture supernatants were collected as described previously [25].  Briefly, P. syringae 
DC3000, JB7 and A9 carrying pMLL600 or pDSK600 cells were grown in KB 
overnight.  Cells were harvested, diluted into fresh KB medium containing selecting 
antibiotics and 2mM IPTG and grown to an OD600 0.6.  Cells were harvested, washed 
once with M63 and transferred to 50 mL M63F, at an OD600 of 0.6.  After 6 hours, 
cells in a 500µL sample were harvested and cell pellets were resuspended in SDS-
PAGE sample buffer for analysis of proteins in whole cell lysates.  An identical 
sample was collected and it was resuspended in 10% SDS to calculate protein 




centrifugation and concentrated 50X using MilliPore Ultra-free centrifugal filter 
devices with a 5 KDa exclusion limit.  Total protein concentration in whole cell 
lysates was measured using the BCA Total Protein Assay kit (Pierce, Rockford).  
Total protein concentration in supernatant samples were measured using the 
MicroBCA Assay Kit (Pierce).   
 
E. coli SG22622 or SG22623 carrying pHIR11 or pLAFR3 and ectopically 
expressing AvrPto or HopPsyA from pDKS600 or pYXSS, respectively, were grown 
overnight in KB medium with proper antibiotics.  One ml of overnight culture was 
used to inoculate 50 ml of M63 media containing fructose and 1% casein hydrolysate 
and cultures were grown to an OD600 of 1.0.   Supernatants and whole cell lysates 
were collected in the same manner as P. syringae.  
Immunoblots.   
Ten µg of total protein from every sample were separated by SDS-PAGE and 
transferred to nitrocellulose membranes.  Immunoblotting was carried out using a 
polyclonal antibody raised against AvrPto, AvrRpt2, HopPsyA or HopPtoM at 1:3000 
dilution.  Commercial antibodies, anti-His (Novagen, San Diego), anti-FLAG (Sigma, 
St. Louis), anti-MBP (New England Biolabs, Beverly) and secondary antibodies 
conjugated to horse radish peroxidase were used following manufacturer’s 
recommendations.  Cross-reactive proteins were visualized using the ECL 




Stability of Effectors. 
Overnight cultures of P. syringae strains expressing AvrPto, HopPsyA or AvrRpt2 
were diluted into M63 media containing fructose as the carbon source to an OD600 of 
0.6 and incubated for 4 h at 25°C.  After incubation, tetracycline (200 µg ml-1) was 
added to inhibit translation.  Cells were harvested at specified time points, lysed in 
sample buffer and fractionated in 12% SDS-PAGE gels.  For E. coli, SG22622 or 
SG22623 were grown overnight at 37°C, diluted into fresh M63F containing 1 % 
casein hydrolysate and grown to an OD600 of 0.6.  After incubation, chloramphenicol 
(200 µg ml-1) was added and samples were collected as in P. syringae.  The half-life 
effectors were calculated from the exponential decay in levels estimated in scanned 




Chapter 4: Identification of a generalized stabilizing factor 
within the hrp cluster 
Introduction 
Although the general mechanism for assembly of the TTSS is considered to be 
conserved in both mammalian and plant pathogens, secretion through P. syringae 
TTSS is considerably different from that in mammalian pathogens.  Firstly, the hrp 
TTSS appears to regulate secretion more tightly than in mammalian pathogens.  For 
example, levels of effectors in supernatants from P. syringae cultures appear to be 10 
to 100-fold lower than observed in cultures from mammalian pathogens.  In addition, 
secretion of reporter constructs used in mammalian pathogens has proven very 
difficult in P. syringae. Secondly, it has been proposed that P. syringae produces 
significantly more effectors than mammalian pathogens [39, 43, 62, 73].  Lastly, a 
majority of the effectors from P. syringae are not associated with a chaperone, 
whereas in mammalian pathogens more than half of the effectors have a dedicated 
chaperone.  So far, only three chaperones have been described for P. syringae [14, 
189, 193] and a total of four more have been postulated according to their localization 
and characteristics [62, 76].  
The exact role of TTSS chaperones remains elusive.  By binding to their 
respective effector, chaperones can sequester and protect them from proteolysis, 
resulting in higher levels of effectors in the cytoplasm [63, 64].  It has been postulated 




by the TTSS [20] to trigger the secretion of an effector.  Most chaperones have been 
defined because they are either necessary for secretion of their specific effectors, 
physically interact with the effectors, or they are involved in stabilizing effectors in 
the cytoplasm [34]; [64, 137, 141].  Chaperones have also been implicated in the 
regulation of transcription of effector genes by acting as either activators or by 
preventing transcriptional repression [49, 104, 126].  Taken together, these data 
suggest that chaperones can be involved not only in stabilizing and targeting effectors 
to the translocation complex, but may also play an important role in controlling which 
effectors are produced and secreted.   
 
We observed previously that effectors were degraded by Lon protease, and that 
chaperones had the ability to protect effectors from this degradation.  We proposed 
that the differential stability of effectors in P. syringae could be a method for 
determining hierarchical secretion of effectors (See Chapter 3).  In our model, 
chaperones would permit the rapid accumulation of an effector in the cytoplasm, and 
in this manner aid secretion.  Considering the important roles of chaperones, it is 
incongruous that P. syringae only contains 7 chaperones for its 60 known or 
candidate effectors [39, 73].  It is possible that not all the chaperones carried in the P. 
syringae genome have been identified.  However, it is important to note that the genes 
for most chaperones in P. syringae and other species are found adjacent or in close 
proximity with their corresponding effector [14, 33, 59, 156, 189, 193].   None of the 
candidate effectors are adjacent to ORFs that exhibit the expected properties of a 




chaperone would be coordinately regulated by HrpL along with the effectors. And 
yet, none of the candidate proteins found in the extensive studies of HrpL-dependent 
genes from DC3000 [62, 76, 206] have the predicted chaperone characteristics either.   
 
It is possible, then, that in P. syringae an alternative to individualized chaperones to 
stabilize effectors evolved.  One alternative is that each of the seven characterized 
chaperones interacts with a large number (> 8) of effectors.  Many TTSS chaperones 
in mammalian pathogens can interact with more than one substrate [148, 149, 155, 
192], although interaction has been limited to two effectors.  A serendipitous 
observation from the results of experiments carried out for Chapter 3, showed that the 
stability of effectors was also affected by the presence or expression of the hrp 
cluster.  These experiments gave birth to the hypothesis that there exists a factor 
within the hrp cluster that is involved in enhancing effector stability, and could 
therefore be a candidate for a generalized chaperone, as opposed to the specific 
chaperones currently accepted.   This generalized chaperone could function 
analogously to individual chaperones of TTSS in mammalian pathogens, and could be 
an adaptation to the large number of effectors necessary for virulence on plant hosts 
for P. syringae.  This study aimed to test the existence of a generalized chaperone in 
P. syringae, whether this factor fits into the description and roles of known 






AvrPto is more stable in the presence of the hrp cluster. 
My previous work had shown that the stability of effectors was affected by the 
presence of Lon protease (Chapter 3).  I proposed that this sort of degradation was 
limiting to TTSS from P. syringae.  Because wild-type cells were capable of secretion 
only when the TTSS was induced, we hypothesized that effectors would be protected 
from Lon-mediated degradation under these conditions in order to be secreted.  We 
studied the abundance and stability of effectors under hrp-inducing or repressive 
conditions (See Materials and Methods).  No difference could be detected between 
AvrPto’s cytoplasmic abundance under hrp-inducing or repressive conditions (Figure 
4-1A, time 0).  Since a difference in the apparent half-lives had been detected 
previously in Lon mutants of E. coli and Psy61 compared to wild-type (See chapter 
3), the same experiment was performed in Psy61 under hrp repressive and inductive 
conditions.  When the cells were grown under hrp-inducing conditions, the half-life 
of AvrPto was about 12 minutes, whereas it was close to 3 minutes under repressive 
conditions (Figure 4-1A).  In addition, the steady state levels of the effector AvrPto 
were also studied in E. coli cells with or without pHIR11, which encodes for the 
whole hrp cluster.  It was found that in the presence of pHIR11, estimated levels of 
AvrPto levels were at least 5-fold higher than in cells without pHIR11 (Figure 4-1B).  
Combined, these results provide evidence for a stabilizing factor for AvrPto contained 




Figure 4-1.  AvrPto is more stable in the presence of the hrp cluster. 
A. An overnight culture of P. syringae Psy61 (wild-type) expressing AvrPto 
from pDSK600 was diluted into fresh media and grown to an OD600 of 1.0.  
The cells were collected and resuspended in either inducing (M63 Fructose) or 
repressive (M63 Fructose with 1% casein) media to an OD600 of 0.6 and 
grown at 25º C for 4 additional hours.  Translation was stopped by the 
addition of tetracycline to a final concentration of 200 µg/ml, and the levels of 
AvrPto were estimated in 250 µl samples.  The cells were collected at the 
indicated times and resuspended in 50 µl SDS-PAGE loading buffer.  Samples 
were fractionated in a 15% SDS-PAGE, and blotted to nitrocellulose and 
probed using anti-AvrPto sera.   
B. AvrPto was expressed from the Lac promoter in pDSK600 in E. coli SG22622 
(wild-type) in the presence of either pHIR11 (+hrp) or pLAFR3 (-hrp).  Cells 
were grown to an OD600 of 0.8, and levels of AvrPto were estimated in a 0.5 
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that is only expressed under hrp-inducing conditions in Psy61, suggesting this factor 
is part of the hrp regulon. 
Search for the stability factor within the hrp cluster 
Because the stability of effector proteins seemed to be affected by the expression of 
the hrp cluster, it was reasonable to predict the existence of a stabilizing factor within 
the cluster.  The stability of AvrPto was tested in an hrpL mutant, lacking the 
alternative sigma factor responsible for hrp gene expression.  If the stability factor 
was part of the hrp cluster, then the levels of AvrPto in the hrpL::Tn strain would be 
decreased compared to the wild-type hrp cluster because the factor would not be 
expressed.  The steady state levels of AvrPto were studied in strains carrying the wild 
type pHIR11 or the transposon-mutated derivative.  E. coli SG22622 (Lon+) were 
transformed with pMLAvrPto600, which expresses a 6xHis tagged AvrPto, and either 
pHIR11 or pHIR11-2084 (hrpL::Tn).  The cells were grown to mid-log phase and the 
whole cell extracts were assayed for the amount of AvrPto in immunoblots.  The 
levels of AvrPto were decreased in the hrpL mutant cells (Figure 4-2), validating the 
hypothesis that the stabilizing factor is contained in the hrp cluster.  The difference in 
levels was not due to a loading difference since the levels of BAP-FLAG were 
equivalent in these strains (Figure 4-2).   
 
It was possible that the enhanced stability of the effectors was due to the 
compartmentalization of the effector into the TTSS and, thus, a physical separation 




Figure 4-2.  Levels of AvrPto in cells expressing hrp operon mutants.   
A. Overnight cultures of E. coli SG22622 (wild-type) carrying different pHIR11 
transposon mutants (containing mutations in different operons of the hrp 
TTSS) and ectopically expressing AvrPto and BAP-FLAG were diluted into 
fresh media until they reached an OD600 of 1.0.  The cells were washed and 
resuspended in M63 fructose with 1% casein to an OD600 of 0.6, and grown 
for 4 hours.  A 0.5 ml aliquot was centrifuged and the cells were resuspended 
in 50 µl of SDS-PAGE sample buffer.  An identical sample was taken but 
resuspended in 50 µl 10% SDS to measure the total protein amounts using the 
BCA kit (Amersham-Pharmacia, NJ).  Ten µg of total protein from the 
samples were separated in a 15% SDS-PAGE and immunoprobed with anti-
AvrPto antibodies.  The blots were stripped with 10M urea and reprobed with 
anti-FLAG antibodies. 
B. Schematic representation of the hrp/hrc operons and the locations for the 













































TTSS, would also result in an inability to protect effectors from degradation.  
Alternatively, it was possible that there existed a chaperone-like molecule that 
protected effectors from Lon-mediated degradation.  If this were the case, then only 
the mutation in one specific gene would abolish the protective effect of expressing the 
hrp cluster.  To differentiate between these alternatives, various pHIR11 mutants 
were used to study their impact on the stability of AvrPto.  These mutants included 
the insertion of a polar transposon in each of six identified hrp operons, except hrpRS.   
The results showed that the stability of AvrPto was still enhanced in four of the 
mutants, suggesting that the effect of the hrp cluster was not due to a sequestering of 
the effector into the secretion apparatus, but could be due to the production of a 
stabilizing agent.  Two mutants, pHIR11-2090 (hrpU) and pHIR11-2093 (hrpA) 
consistently showed a decreased amount of AvrPto when assayed (Figure 4-2), 
suggesting that the stabilizing factor was contained in one or both of these operons.    
The levels of AvrPto in the hrpK operon mutant also appeared to be decreased (~ 
50% of wild-type, data not shown), however, these levels varied in the different trials 
carried out, and therefore were not further pursued.  
 
Attempts were made to verify the stabilizing effect of the hrpA and hrpU operons.  
Each operon was cloned into pCR-XL and co-expressed with AvrPto.  Both the hrpA 
and hrpU operons were expressed from the Lac promoter present in pCR-XL and 
induced with IPTG.  When expressed at the same time as AvrPto, both operons were 





Figure 4-3.  The hrpA and hrpU operons can stabilize AvrPto. 
A.  Wild-type E. coli SG22622 carrying pAvrPto600 were transformed with either 
pLAFR3 (empty vector, open circles) or the cosmid clone pHIR11 (carrying a 
functional hrp cluster, closed circles).  Overnight cultures were diluted in fresh M63 
Fructose with 1% casein hydrolysate and grown to an OD600 of 0.6.  Translation was 
stopped by the addition of chloramphenicol to a final concentration of 200 µg/ml, and 
250 µl samples were taken at the times (min) indicated.  Cells were collected and 
resuspended in SDS-PAGE loading buffer.  Whole-cell lysates were separated in a 
12% SDS-PAGE, and levels of AvrPto were estimated as before.  The abundance of 
AvrPto was measured relative to its initial amounts at time 0 min. B.  The levels of 
AvrPto in cells carrying inactive pHIR11-2093 (hrpA::Tn, solid line, open squares); a 
construct expressing the entire hrpA operon in pCR-XL (solid line, closed squares); 
hrpA, hrpZ, and hrpB genes of the hrpA operon in pCR-XL, pTophrpAXL (dashed 
line, open triangles); or hrcJ, hrpD, and hrpE genes of the hrpA operon in pCR-XL, 
pBottomhrpAXL (dashed line, closed triangles).  C.  The levels of AvrPto were 
estimated also in cells expressing inactive pHIR11-2090 (hrpU::Tn, solid line, open 
diamonds);  a construct expressing the entire hrpU operon in pCR-XL (solid line, 
closed diamonds);  hrcP, hrpQa, hrcQb,and  hrcR genes of the hrpU operon in pCR-
XL, pTophrpUXL (dashed line, star);  or hrcS, hrc, hrcT, and hrcU genes of the hrpU 
operon in pCR-XL, pBottomhrpUXL (dashed line, double stars).  Experiments were 






















































variability was observed.  The experiments were performed a total of 5 times, but 
only 3 out of those gave the reported results.  The other 2 trials resulted in opposite 
outcomes in which AvrPto was not stabilized at all by the presence of the operon 
(data not shown).  The outcome may be a result of inconsistencies in expression from 
the lac promoter in the pCR-XL system or a problem with the experimental approach. 
 
Identification of the gene encoding the stabilizing factor.   
 
In order to identify the gene responsible for the stability, half of the genes from each 
operon was subcloned individually into pCR-XL and their effects on AvrPto were 
studied.  Neither half of the hrpA operon had the ability to stabilize AvrPto (Figure 4-
3C).  The results from the hrpU operon are very similar.  Neither the 5’ nor 3’ genes 
of the operon could consistently stabilize AvrPto (Figure 4-3D).  The experiments 
suggest that there was a problem with the expression of the cloned genes, or more 
than one gene product is necessary for the stabilizing effects observed on AvrPto.  
Alternatively, the approach used was improper for this study and could not be relied 
upon to identify the stabilizing factor in the hrp cluster.  As a consequence, 
biochemical approaches were attempted to ascertain the nature of the stabilizing 
factor. 
 





Building on the hypothesis that the generalized stabilizing factor would be acting in a 
similar fashion to a chaperone that physically interacts with its effector, three 
different biochemical methods were used to try to identify proteins which interact 
with AvrPto and other effectors:  Far Westerns, crosslinking, and column binding 
experiments.  Each of these methods probes for interacting proteins, that, if found, 
would have to be characterized using peptide sequencing or mass spectrometry 
analysis.  The following experiments were performed on at least two effectors, 
however only representative results from HopPsyV1 are shown. 
 
Far Westerns.  Far-Western blotting is a method of probing a nitrocellulose or PVDF 
membrane, containing immobilized proteins, with another protein to detect specific 
protein-protein interactions.  The method involves transferring cell extracts to a 
membrane, allowing a 8-24 h refolding period, and then overlaying the blot with a 
soluble protein that may bind to one or more immobilized proteins on the blot.  After 
the overlay, interacting proteins are visualized by immunodetection based on the 
probing protein.  A band would appear on the blot at the location where the 
interacting protein was located.  For these experiments 6xHis tagged effectors were 
purified using Ni-NTA columns and used as the probing protein. Out of five 
effectors, two, AvrPto and HopPsyV1, were purified at high enough concentrations to 
carry out the experiments. The purified effectors were used to probe blots of whole 
cell extracts from different strains and growth conditions, including P. syringae 
grown under hrp-inducing and non-inducing conditions, P. syringae hrpL mutants, 




control an E. coli strain that expresses ShcV1 was used.  ShcV1 is the predicted 
chaperone for HopPsyV1 and it’s expected to interact physically with its effector.    
Neither AvrPto nor HopPsyV1stably associated with another protein (Figure 4-4).  
The experiments were performed with 10X more effector than recommended in other 
methods [167], but no interactions could be detected.  The major limitation of this 
method is that it relied on a very strong physical interaction between the effector and 
the stabilizing factor.  It is possible that the interaction between this generalized factor 
and each effector is in reality very weak, and thus, this approach could not be used.  
Because the effector used as a probe would be washed away easily during the 
procedure it would be impossible to identify interacting proteins properly.  
Consequently, other more sensitive approaches were used.  
 
Column-binding experiments.  These experiments were performed by immobilizing 
the effectors on a Ni-NTA column by virtue of a 6xHis epitope, and passing whole 
cell extracts through the column.  Those proteins that interact with the effector would 
remain immobilized in the column until both proteins are eluted.  The experiments 
were tried with AvrPto, HopPsyV1, HopPsyB1 and HopPtoG.  Both HopPsyV1 and 
HopPsyB1 are proposed to interact with their chaperones ShcV1 and ShcB1, 
respectively, and these interactions were used as controls for detecting protein-protein 
interactions.  Only the representative results from HopPsyV1 are shown, but similar 





Figure 4-4.  Far Western Analysis of effector interacting proteins. 
HopPsyV1 was purified from E. coli SG22622 wild type cells using the Ni-NTA 
agarose slurry (Qiagen, CA) following manufacturer’s instructions. Ten µg of 
purified protein were diluted in interaction buffer and incubated with a blot of whole 
cell extracts for 2 hours.  The blot was washed once with wash buffer (10mM Tris-
HCl, 0.01% Tween-20) and the blot was probed with anti-His antibodies and 
recommended by the manufacturer.  Lanes 1:  SG22623 (∆lon) pLAFR3 (empty 
vector);  2:  SG22623, pHIR11 (expressing a functional hrp TTSS);  3:  SG22623, 
pShcV1D (expressing ShcV1 chaperone);  4:  P. syringae Psy61 (wild-type), 
inducing conditions;  5:  Psy61, repressive conditions;  6:   Psy61-2084 (hrpL::Tn, 
hrp-), inducing conditions;  7:  P. syringae DC3000 (wild-type), inducing conditions;  
8:  purified HopPsyV1 (as a positive control for the immunoblot).  Similar results 



















immobilized on the column as is evident because very low amounts of HopPsyV1 of 
other effectors were detected in the flow through or wash fractions of the column 
(Figure 4-5A).  The effectors were not eluted from the column by the whole cell 
extracts from Psy61 or the secondary washes (Figure 4-5A).  The buffers used were 
sufficient to elute the effectors, as is evident because of the high concentration of 
HopPsyV1 in the eluate fraction (Figure 4-5A).  HopPsyV1 was always purified as 
two bands at around 69 KDa and 73 KDa, this molecular weight shift might be the 
result of the loss of the peptide added by cloning the protein into the pTrcHis2 vector.  
However, too many additional proteins could be detected in the elution after 
application of whole-cell extracts from Psy61, even under the most stringent of wash 
buffers (Figure 4-5A).  These results did not make it possible to identify a single 
protein that was directly interacting with the effector.  Moreover, the eluates of 
different stains all resulted in the same protein species (Figure 4-5B).  Even cell 
extracts of a strain expressing the cognate chaperone, ShcV1, did not result in a band 
at the expected 18 KDa, suggesting that the observed bands were not specifically 
interacting with the effector, but were some form of contamination.  Regardless of the 
wash protocol followed, the eluate was always contaminated.  The most obvious 
limitation to this approach was that it did not appear to be functioning adequately.  
The controls used to test the interaction between an effector and its cognate 
chaperone did not result in the expected purification of the chaperone.  Those results 





Figure 4-5.  Column binding experiments. 
A. A whole cell lysate (WC) of E. coli SG22622 (wild-type) expressing 
HopPsyV1was mounted on a Ni-NTA agarose column (Qiagen, CA) as 
recommended by the manufacturer.  The lysate was allowed to pass through 
the column by gravity (FT) and then washed three times with a stringent 
buffer (W) containing 50 mM imidazole.  A cleared lysate from Psy61 grown 
under inducing conditions created as recommended by the manufacturer 
(Qiagen, CA) was passed through the column (FT2).  The column was washed 
once again with a mild buffer (W2) containing only 10 mM imidazole and 
eluted with elution buffer (E) containing 250 mM imidazole as recommended 
by the manufacturer.  The results presented are from one experiment but it is 
representative of three attempts.   
B. Whole cell extracts were treated as before, except that cell lysates from the lon 
null cells SG22623 carrying pLAFR3 (lane 1), pHIR11 expressing a 
functional hrp TTSS (lane 2), or the wild type cells SG22622 carrying 
pShcV1D which expressed the ShcV1 chaperone (lane 3), pLAFR3 the empty 
vector (lane 4), or pHIR11with the hrp TTSS (lane 5) were passed through the 
column and the eluates were run on a SDS-PAGE side by side.  No difference 
in the proteins detected could be observed.  Similar results were obtained with 
































Cross-linking experiments. Two cross-linking agents were used to covalently link 
proteins that are in close proximity.  If there are proteins that physically interact with 
the effectors, then the crosslinking would result in a species with a higher molecular 
weight than the effector.   Formaldehyde and DSP were used as described in other 
methods [167].  After crosslinking, cell extracts were either fractionate by SDS-
PAGE and immunoblotted, or the poteintial effector-interacting protein complex was 
purified on the Ni-NTA columns as described before.  These experiments were 
performed on AvrPto and HopPsyV1.  As a positive control, ShcV1 was expressed 
and its interaction with HopPsyV1 was monitored.  For neither of these proteins or 
with either of the methods was there a detectable weight shift that could be attributed 
to interaction with another protein (Figure 4-6).   As was the case for the Far 
Westerns, the major limitation of this approach was that it depended on a very 
intimate and strong interaction between the effector and the proposed generalized 
stability factor.  If this interaction does not occur, then no proteins could be cross-
linked to the effector.  These results suggest that the methods used were not properly 
optimized for the protein-protein interaction under scrutiny, and that the positive 





Figure 4-6.  Crosslinking experiments. 
A. Overnight cultures of SG22623 (∆lon) carrying pHIR11 that expresses a 
functional hrp TTSS (lanes 1 and 4), the empty vector, pLAFR3 (lanes 2 and 
5), or pShcV1D expressing the ShcV chaperone (lanes 3 and 6) and co-
expressing HopPsyV1 were diluted into fresh LB media and grown to an 
OD600 0.6.  DSP to 1 mM was added to one half of the culture (lanes 4 – 6) 
and the cells were incubated for two additional hours.  A 0.5 ml aliquot 
sample was centrifuged and the pellet was resuspended in 50 µl of SDS-
PAGE loading buffer.  The samples were fractionated by SDS-PAGE and 
immunoblotted with anti-His antibodies.    
B. SG22623 (∆lon) cells were treated as above except that formaldehyde (10 
mM) was used for crosslinking instead of DSP and the incubation time was 
reduced to 30 min.  After the incubation 6xHis tagged moieties were purified 
using the Ni-NTA agarose slurry and analyzed by immunoblots.  Similar 
results were obtained with AvrPto.  Lanes 1 and 5: no vector;  lanes 2 and 6: 
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Secretion through the TTSS of P. syringae is different from mammalian pathogens in 
various ways.  Most notably, the number of proteins which are substrates for TTSS in 
P. syringae is very high (>60) compared to less than 15 for other pathogens [39, 43, 
62, 76].  All effector genes are controlled by the alternative sigma factor, HrpL, and 
there are no known mechanisms for regulation of their transcription and/or 
translation.  In P. syringae, however, chaperones appear to be associated with a very 
small minority of these effectors [62, 75].  These facts pose a dichotomy in P. 
syringae:  either chaperones are not important for its TTSS; or P. syringae has found 
an alternative method for carrying out the roles of individual chaperones.  The 
observation presented here that effectors can be generally stabilized by expression of 
the hrp regulon in P. syringae, provides some evidence that indeed there is a need for 
at least one of the chaperone activities prior to secretion.   In addition, the recent 
studies that show that three chaperones, ShcA, ShcM and ShcV, are necessary for the 
secretion of their corresponding effectors [14, 189, 193] underlines the necessity for 
chaperone functions in the hrp TTSS.  It is likely, then, that P. syringae requires 
chaperone functions for secretion, but developed a novel way to achieve these 
functions. 
 
The results obtained in the course of this study suggest that there is a factor within the 




appeared to be more abundant and had longer apparent half lives when the hrp 
regulon was expressed in P. syringae.  Those effectors were also stabilized in E. coli 
cells expressing the hrp cluster, suggesting that the protein(s) responsible for 
stabilization was encoded by one of those genes.  I proposed that this factor could act 
as a generalized chaperone that could protect effectors from proteolysis, and also 
allow their secretion through the TTSS.  This proposed generalized chaperone would 
act analogously to other TTSS chaperones.  Firstly, it was necessary for the 
cytoplasmic stabilization of effectors.  Secondly, it would be regulated as part of the 
hrp regulon by HrpL.  Thirdly, it would physically interact with the effectors and 
form either a “secretion competent” structure [179], or alternatively, a three 
dimensional structure that would be recognized by the secretion apparatus [20].  
Lastly, the generalized chaperone would be necessary for proper secretion of the 
effectors.  
 
The initial attempts to identify the generalized chaperone were based on its ability to 
stabilize effectors in the cytoplasm.  To this end, various transposon mutations of the 
operons in the hrp cluster were used to find mutants where the abundance of AvrPto 
was decreased when compared to the wild-type hrp cluster.  The approach was useful 
to identify two operons that had the ability to stabilize AvrPto, the hrpA and hrpU 
operons.  The hrpA operon consists of hrpA, hrpZ, hrpB, hrpJ, hrpE and hrpD.  As 
shown in Table 1-1 (page 27), HrpA (the main component of the TTSS needle [163]), 
HrpZ (an HR elicitor), and HrpB are all secreted proteins, and might not function as 




be cytoplasmic, and at least HrpD has been shown to also associate with membranes 
[140].  Most interestingly, however, is the fact that HrpE is the FliH/YscL homolog 
(Table 1-1).  FliH and YscL have been proposed to interact with FliI and YscN, the 
ATPases involved in flagellar biosynthesis and Yersinia TTSS [96, 204].  FliH 
appears to interact with chaperone/substrate complexes and seems to be involved in 
the initial docking of flagellar export substrates [183] (see Figure 1-2, pg. 26).  In 
Yersinia, YscL interacts with YscK [96], which is the HrpD homolog (Table 1-1).  
Thus, it is possible that the stability factor in P. syringae could indeed be one of these 
docking proteins.  The function of HrpJ is still unknown, and therefore could also be 
an excellent candidate for the stability factor.  In the future, experiments that directly 
address the ability of HrpD, HrpE, and HrpJ to interact with specific effectors should 
be conducted.    
The hrpU operon consists of hrcU, hrcR, hrcS, hrcT and hrcQa /hrcQb and is mostly 
responsible for the formation of the inner membrane structure of the TTSS [89].  
Inner membrane components of the flagellar TTSS are known to interact with 
chaperone/substrate complexes [204], and are also involved in the initial docking onto 
the system [183].  Therefore, it is most likely that the stability factor is one of the 
soluble components expressed from the hrpA operon.   Possibly, in the absence of the 
proper inner membrane components, the soluble complex formed between the 
effector and the soluble components dissolves quickly, and hence the effector would 
be prone to Lon-mediated degradation.  
 




stabilization, but none of the results was sufficiently convincing to pinpoint the nature 
of the stabilizing factor.  The major limitation of the genetic approach was the lack of 
sensitivity of the antibody used during the study.  The antibody was cross-reactive 
with too many proteins which made it difficult to determine the actual levels of 
AvrPto in the blots, and therefore, unreliable.  In the future, these experiments should 
be performed using more precise antibodies, such as anti-HopPsyA and anti-
HopPtoM which were recently acquired.  In addition, these experiments should also 
be conducted using the native P. syringae background, since it would be more 
accurate than the E. coli-based screen.  There are transposon mutants in all the 
operons tested in this study, and therefore, a complete screen of the hrp cluster could 
be performed. 
 
The second set of experiments attempted in this study focused on the identification of 
a protein that could physically interact with effectors.  Based on other TTSS, the 
stabilizing factor could act as a chaperone that has multiple substrates, such as SycD, 
IpgC, and SycH in Shigella, and Yersinia spp. [148, 149, 155, 192].  Three different 
biochemical methods for identifying protein interactors were used.  All of these 
attempts were based on the premise that the stability factor could physically interact 
with the effectors.  In some cases, the methods were modified to fit the conditions 
necessary for even weak interactions.  Since the positive controls did not yield the 
expected results these experiments remain inconclusive.  More effort should be 
dedicated to enhance the effectiveness of these methods and to obtain the proper 





It is essential to keep in mind that the generalized stability factor may influence other 
processes that may stabilize the effectors.  For example, the stability factor may be 
involved in the post-translational modification of the effector, therefore protecting it 
from degradation.   However, none of hrp the gene products is predicted to have an 
enzymatic activity capable of modifying the effectors, and hence it is unlikely that the 
stabilizing factor is involved in such a modification.  Alternatively, it may regulate 
protease activity and in this manner protect effectors.  Other results comparing 
proteolysis in P. syringae between hrp-inducing and hrp-repressing conditions have 
shown that there is no difference in the general turnover of proteins (Bretz, 
unpublished results).  These results suggest that the activity of proteases is the same 
under both conditions and supports the idea that effectors are differentially protected 
under the two different conditions.   The assay has not been carried out specifically 
for Lon, and so it is possible that the affinity of Lon for the effectors is different under 
the two situations.  Since the stability factor could be directly interacting with the 
effector, or involved in other mechanisms that change the affinities of Lon, it is vital 
that both genetic and biochemical approaches with enhanced sensitivity be used to 
discover the stability factor.   
 
In conclusion, during this study various attempts were conducted to identify a 
possible generalized stability factor for TTSS in P. syringae.  This stability factor 
would accomplish the roles of other TTSS chaperones by acting on a wide range of 




stability factor still remains to be discovered. 
Materials and Methods 
Bacterial Stains and Media.   
Strains and plasmids used in this study are described in Table 4-1.  Bacteria were 
routinely grown on King's B medium [12].  Plasmids were propagated in E. coli 
DH5α.  E. coli strains were grown at 37ºC, and Pseudomonas syringae strains were 
grown at 25ºC.  LB and M63 minimal salts media were used as described previously 
[167].  M63 medium was supplemented with 1mM MgSO4 and 1% fructose (M63F).  
The following antibiotics were added where needed at the indicated concentrations 
(in micrograms per milliliter):  ampicillin, 200; kanamycin, 50; spectinomycin, 100, 
tetracycline, 25; nalidixic acid, 50; rifampicin, 200; and chloramphenicol; 30. 
 
Table 4-1.  Strains and Plasmids. 
Strain or plasmid Genotype or phenotype Reference or source
Strains   
E. coli   
 DH5α endA1 hsdR17 (rk- mk-) supE44 thi-1 recA1 
gyrA96 relA1 ∆(argR-lacZYA) 
U169φ80dlacZDM15 
Invitrogen 
SG22622 cpsB::lacZ ∆ara malP::lacIq S. Gottesman 




SLR400 araD139 ∆(ara leu)7697 derivative of 
MC4100 
S. Benson 
 TOP10 F- mcrA (mrr-hsdRMS-mcrBC) 80lacZ
M15 lacX74 recA1 ara 139 (ara-leu)7697 
galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
Pseudomonas syringae  
Psy61 Wild-type, Nalr , HR+ 
Weak bean pathogen 
[15] 
Psy61-KL11 Nal r Kanr , lon::Tn [25] 
Plasmids   
pAvrRpt2D 1.0 kb PCR product containing avrRpt2 
cloned into pDSK519 
This work 
pDSK519 Broad-host range vector, IncQ Kanr [107] 
pDSK600 Broad-host range vector, IncQ Spr [147] 
pFLAG-CTS-BAP Bacterial Alkaline Phosphatase in pFLAG-
CTC 
Sigma-Aldrich 
pHIR11 pLAFR3 derivative carrying P. syringae pv. 
syringae 61 hrp/hrc cluster, Tcr
[85] 
pHIR11-2074 hrpL:Tn derivative of pHIR11 [84] 
pHIR11-5134 hrpK:Tn derivative of pHIR11 [84] 
pHIR11-2075 hrpJ:Tn derivative of pHIR11 [84] 
pHIR11-2084 hrpU:Tn derivative of pHIR11 [84] 




pHIR11-2093 hrpA:Tn derivative of pHIR11 [84] 
pHopPsyB1trc hopPsyB1 cloned into pTrcHis2 This work 
pHopPsyEtrc hopPsyE cloned into pTrcHis2 This work 
pHopPtoGtrc hopPtoG cloned into pTrcHis2 This work 
pHopPtoMtrc hopPtoM cloned into pTrcHis2 This work 
pHopPsyV1trc hopPsyV1 cloned into pTrcHis2 This work 
pLAFR3 Tcr, IncP1  [177]  
pLLHrpAXL hrpA operon cloned into pCR-XL This work 
pLLHrpUXL hrpU operon cloned into pCR-XL  This work 
pLLBottomHrpAXL 5’ genes of hrpA operon cloned into pCR-
XL 
This work 
pLLBottomHrpUXL 5’ genes of hrpU operon cloned into pCR-
XL 
This work 
pLLTopHrpAXL 5’ genes of hrpA operon cloned into pCR-
XL 
This work 
pLLTopHrpUXL 5’ genes of hrpU operon cloned into pCR-
XL 
This work 
pMLAvrPto600 0.45 kb PCR cloned  as EcoR1-HindIII into 
pDSK600 
[25] 
pMLL600 0.4-kb PCR product containing hrpL  
cloned into pDSK600 
This work 
pSGAS 3.6-kb fragment containing hopPsyA in 
pYXSS 
[80] 
pSHAMB hopPsyA cloned into pMLB1034 [80] 




pShcMD 0.5 kb PCR product cloned into pDSK519 This work 
pShcV1D 0.5 kb PCR product cloned into pDSK519 This work 
 General DNA manipulations.   
Restriction enzymes were purchased from Invitrogen (Bethesda, MD).  T4 DNA 
ligase was acquired from New England Biolabs (Beverly, MA) and used according to 
the manufacturer's recommendations.  Basic manipulations were done using standard 
procedures.  PCRs were performed using a PCRSprint thermal cycler (Hybaid, 
Ashford, UK) with 50 µl reaction volumes.  Unless indicated otherwise, ProofPro 
polymerase (Continental Lab Products, San Diego) was used to amplify fragments for 
cloning. 
 
Cloning of operons into pCR-XL   
The regions containing the hrpA and hrpU operons, including their ribosome binding 
site, were amplified from Psy61 genomic DNA using the following primers: hrpA 
complete operon A1 (TACCGTCGCATCAAGGAAT) and A2 
(CCATTTTCGCCGCAAGA); 5’ region A1 and A3 
(GCAGGCCCGTTCTCTTCGT); 3’ region A4 (ACGAAGAGAACGGGCCTGC) 
and A2, hrpU complete operon U1 (GATCCTCGACCACTTAGCA) and U2 
(GGTACGCGTATGGCTAAAC); 5’region U1 and U3 
(AACTACAGTTTGTCGGCGTTG); 3’ region U4 
(CAACGCCGACAAACTGCAG) and U2. The products were cloned into pCR-XL 




instructions.  The inserts were verified by sequencing. 
Immunoblots.   
Ten µg of total protein from every sample were separated by SDS-PAGE and 
transferred to nitrocellulose membranes.  Immunoblotting was carried out using a 
polyclonal antibody raised against AvrPto at 1:3000 dilution.  Commercial antibodies, 
anti-His (Novagen, San Diego), anti-FLAG (Sigma, St. Louis), and secondary 
antibodies conjugated to horse radish peroxidase were used following manufacturer’s 
recommendations.  Cross-reactive proteins were visualized using the ECL 
chemiluminescence kit (Amersham-Pharmacia, Piscataway). 
 
Stability of Effectors. 
Overnight cultures of P. syringae strains expressing AvrPto, HopPsyA or AvrRpt2 
were diluted into M63 media containing fructose as the carbon source to an OD600 of 
0.6 and incubated for 4 h at 25°C.  After incubation, tetracycline (200 µg ml-1) was 
added to inhibit translation.  Cells were harvested at specified time points, lysed in 
sample buffer and fractionated in 12% SDS-PAGE gels.  For E. coli, SG22622 or 
SG22623 were grown overnight at 37°C, diluted into fresh M63F containing 1 % 
casein hydrolysate and grown to an OD600 of 0.6.  After incubation, chloramphenicol 
(200 µg ml-1) was added and samples were collected as in P. syringae.  The half-life 
effectors were calculated from the exponential decay in levels estimated in scanned 





Purification of Effectors. 
C-terminally 6xHis tagged effectors were purified using the Ni-NTA agarose slurry 
(QIAGEN, CA) under native conditions as recommended by the manufacturer.  
 
Far Western  Blots. 
Ten µg of whole cell lysates from Psy61 and Psy61-2084 under inducing or 
repressing conditions as described by [200] were separated by SDS-PAGE and 
transferred to a PVDF membrane.  Blots were incubated with up to 10 µg of purified 
effector in binding buffer (10 mM MgSO4, 10mM Tris-Cl pH 7.8) for two hours.  
Blots were washed with PBS buffer once for 10 min, and then immunoprobed using 
anti-His antibody as recommended by the manufacturer.   
Column Binding. 
Whole cell lysates of cells expressing 6xHis tagged effectors were prepared following 
the instructions for native isolation of proteins (Qiagen, CA) with the exception that 
after four washes the proteins were not eluted.  Instead, a 3 ml sample of a whole cell 
lysate of Psy61, Psy61-2084 (inducing and repressing conditions), SG22623(pHIR11) 
or SG22623(pLAFR3) was allowed to pass through the column in 0.5 ml aliquots.  
The column was then washed with wash buffer (50 mM NaH2PO4 , 300 mM NaCl, 20 
mM imidazole pH 8.0) three times and eluted with elution buffer (50 mM NaH2PO4 , 




through and washes to detect any leaking of the bound effector.  After elution, 
proteins were separated by SDS-PAGE, and either stained with Coommassie Brilliant 
Blue or immunoprobed for the effector to verify the proper functioning of the column. 
Crosslinking experiments. 
Cells were grown to an OD600 of 0.8 at which point either formaldehyde (10 mM) or 
DSP (1 mM) were added.  Cells were incubated for an additional 30 min with 
formaldehyde or two hours with DSP.  Whole cell extracts were created by taking a 
0.5 ml aliquot, centrifuging, and resuspending the pellet in 50 µl of SDS-PAGE 
sample buffer and separating them by SDS-PAGE and immunoprobing for the 
effector.  Alternatively, after the crosslinking, cell lysates were created under native 
and denaturing conditions and incubated with the Ni-NTA agarose slurry for 1 hour 
and treated as recommended by the manufacturer.  Eluted proteins were detected by 





Chapter 5:  General Conclusions and Future Directions 
 
This work was successful in identifying and characterizing a novel effector in P. 
syringae Psy61, HopPsyL.  This effector was shown to be necessary for virulence in 
Phaseolus vulgaris cv Kentucky Wonder, and was an avirulence determinant on 
many non-host plants.  In addition, effectors were found to be hypersecreted and 
more stable in strains lacking Lon protease.  From those experiments, a novel model 
on how P. syringae regulates secretion of effectors through its TTSS was proposed.  
The model stipulates that the cytoplasmic abundance of effectors is limiting to 
secretion, and suggests that an order for effector secretion could be established 
depending on the relative abundances of different effectors.  This study found that 
effectors were protected from Lon-mediated degradation by their corresponding 
chaperones, therefore clarifying the role of chaperones in P. syringae. The study also 
found evidence for a generalized chaperone used in P. syringae secretion in order to 
stabilize effectors prior to secretion.  This general chaperone could be another method 
for imposing hierarchy in effector secretion, and an adaptation to the great number of 
effectors present in the P. syringae genome.  
 
One of the major impasses of studying secretion through the P. syringae TTSS was 
that the process is very tightly regulated.  I found that lon mutants were capable of 
hypersecreting effectors (Chapter 3) [25], and that bypassing the regulation of the hrp 




3).   The hypersecretion was due to an enhanced amount of the effector in the 
cytoplasm, mainly because effectors were not degraded by Lon in that strain (Chapter 
3).   These results led me to propose that secretion was limited by the cytoplasmic 
amount of effectors available, and that selection of secretion substrates in P. syringae 
could be dictated by the comparative abundance of each effector in the cytoplasm 
(Figure 5-1a).  This model was novel in the field and could help to explain the 
manner in which a hierarchy of effector secretion could be established in P. syringae.  
The model implies that effectors present at high concentrations would be secreted 
more readily, and would accumulate in the host more rapidly than those at low 
concentrations. The model is exciting because up to now, the only method proposed 
for imposing an order of secretion has been through chaperones.   However, most 
TTSS have fewer chaperones than effectors, and thus it was unclear how the order 
could be established for effectors that don’t appear to have a cognate chaperone.  The 
model is especially important for plant pathogens that have only a small number of 
chaperones compared to the vast number of effectors [76], and thus could explain 
how those effectors are selected for secretion.  
 
I found that chaperones positively affected the stability of effectors in the P. syringae 
cytoplasm by protecting them from Lon-mediated degradation.  Therefore, I was able 
to clarify the role of these chaperones in this system.  The results fit in with my 
proposed model of effector secretion, since an effector that interacts with its 
chaperone is more stable and present at higher amounts in the cytoplasm, and 





Figure 5-1.  Substrate selection in the TTSS of Pseudomonas syringae. 
A. (i)  Two effectors wait to be secreted.  Effector A is more stable and more 
abundant, and therefore is secreted more readily than Effector B.  (ii)  The 
relative abundance of Effector B rises and becomes a proper substrate for 
secretion through the system.  Thus Effector B is secreted later than Effector 
A, and it takes a longer time for accumulation of Effector B in the host cell. 
B. (i)  The effector is not stable without its chaperone, and consequently its 
cytoplasmic abundance is limited and not sufficient for proper secretion.  (ii) 
In the presence of its chaperone, the effector is stabilized and begins to 











Interestingly, effectors interacting with chaperones were also susceptible to Lon 
protease to different degrees, suggesting that here chaperones might also be involved 
in imposing a secretion hierarchy as in the Yersinia and flagellar biosynthesis TTSS 
[3, 198].           
 
Many tests need to be conducted, however, in order to understand if the model I 
proposed actually describes what occurs in P. syringae.  For instance, eight effectors 
were analyzed in this study, which is only a fraction of the total number of effectors 
produced by P. syringae strains.  Moreover, most of the sampled effectors belonged 
to different strains.  The observation that there exist two categories of effectors due to 
their difference in stability might be a consequence of the small sample used for the 
study, and might not reflect what really occurs in the bacterial cell.  More effectors, 
from a single strain, should be analyzed to determine if the model is still valid. It still 
remains to be shown whether secretion through the hrp TTSS is ordered in a similar 
fashion to Yersinia or flagellar biosynthesis [142, 198].  However, the available 
technology is not sensitive enough for this type of analysis, since secretion from P. 
syringae is very limited and reporter constructs cannot be used effectively to analyze 
the amount of secretion.  There might be the possibility of using the adenylate cyclase 
reporter assay as recently published [169].  Although the assay appears to be 
quantitative in nature [169], it is still not known whether it is sufficiently sensitive to 
detect very low levels of translocated effectors, or whether it can differentiate 
between early and late secretion.   Furthermore, if the model we propose is applicable 




to secrete elevated amounts of effectors, then it could be possible to assay the 
existence of “early” and “late” secretion substrates in those species, and their 
correlation with Lon-mediated degradation. 
 
A contradiction within our proposed model was that effectors that have very short 
half lives, and therefore do not accumulate in the bacterial cytoplasm, are still 
secreted through the TTSS, albeit at an unknown rate.  For example, HopPsyB has 
been shown to be secreted and translocated through the system [33] despite its short 
half life (>3 min).  Our observation that AvrPto and other effectors were stabilized 
when the hrp regulon was expressed provided evidence of the existence of a 
generalized stability factor that could potentially be in charge of stabilizing effectors.  
This generalized stability factor would accomplish the roles of chaperones, and 
possibly form the three-dimensional structure used for targeting an effector to the 
secretion port, as discussed later.  The proposed factor could have distinct affinities 
for different effectors, that might allow it to act as the regulator of substrate selection, 
much like FliK in flagellar biosynthesis [106, 142], or Spa32 in Shigella flexneri 
[133]. This stability factor, however, still remains to be identified, and its real role in 
TTSS from the hrp system needs to be elucidated.  More genetic and biochemical 
attempts to identify the generalized stability factor should be carried out as discussed 
in greater detail in Chapter 4.     
 
I determined that the protection granted by the chaperone ShcM on its cognate 




terminal motif leading HopPtoM to Lon-mediated degradation did not appear to 
overlap the chaperone-binding domain.  The chaperone probably protected the 
effector because of the formation of some Lon-insensitive structure.  Interestingly, 
this structure might also function as the elusive TTSS signal, as discussed below.  It 
would be of great interest to locate the Lon-targeting motif of HopPtoM and other 
effectors more precisely.  It is possible that the identified motif would be different 
between “early” and “late” secretion substrates, and therefore would provide us with 
the molecular basis for the difference, and a possible mechanism for imposition of the 
proposed secretion hierarchy.  The targeting sequence from SulA [81, 95] was not 
present in HopPtoM or other effectors, and no consensus sequence that might target 
effectors to Lon could be discerned.    To clearly define the Lon-targeting motif, 
further experiments using the MBP fusion strategy should be attempted.  Both 
truncations of the C-terminal domain of HopPtoM, and N- and C-terminal truncations 
of other TTSS effectors should be studied.   
 
The results from my studies, namely that the secretion from P. syringae is limited by 
Lon-mediated degradation of effectors, also helps clarify the controversy surrounding 
the TTSS secretion signal.  My results imply that the secretion signal is contained in 
the peptide, and not the mRNA as had previously been proposed [7, 9, 145].  If the 
signal was in the form of mRNA, then it would be likely that secretion occurred co-
translationally, and would imply that there exists a mechanism for the ribosome to get 
in close contact with the TTSS, the idea known as “co-translational translocation” [9].  




for the cytoplasmic accumulation of effectors, as observed here and elsewhere [184].  
In addition, the degradative effects of Lon protease should not have an impact on the 
secretion of effectors, as I observed.  It is fascinating that the field of flagellar 
biosynthesis had been through a very similar situation trying to explain their secretion 
signal [105, 131], and to date both signals remain uncertain [132, 162].  
 
Since this study was initiated, three P. syringae genomes have been partially or 
completely sequenced [28]; www.tigr.org; www.jgi.doe.gov), and several studies 
have attempted to identify novel effectors [27, 33, 62, 76, 128, 158, 206].  One of 
these studies [158], postulated a set of rules that defined the peptidic secretion signal 
of P. syringae effectors.  The rules postulate that the N-termini of effectors are 
generally basic amphipathic helices with several restrictions on the amount and 
location of non-polar and cysteine residues.  A survey I conducted of thirteen known 
or candidate effectors revealed that the majority did not fit these characteristics.  
HopPsyL, the novel effector identified in Chapter 2, did not fit three of the postulated 
characteristics (Table 5-1), and other effectors long known to be secreted and 
translocated also failed at least two of these rules (Table 5-1).  Indeed, proteins 
lacking any of those characteristics were recently shown elsewhere to be secreted and 
translocated [169].  Thus, a consensus sequence that could function as a secretion 
signal has not been identified by me or others [62]. 
 




Table 5-1.  The proposed secretion signal of P. syringae effectors is not 
conserved. 
Effector Rule 1a Rule 2 Rule 3 Rule 4 Rule 5 Rule 6 
HopPsyA No Yes No Yes Yes Yes 
HopPsyL No Yes Yes No No Yes 
AvrPphE Yes Yes Yes No Yes Yes 
AvrPphC Yes Yes Yes No Yes Yes 
HopPtoB1 No Yes Yes No Yes Yes 
HopPtoB2 No Yes Yes No Yes Yes 
AvrXcT Yes Yes Yes Yes Yes Yes 
HopPsyE1 Yes Yes Yes No Yes Yes 
HopPsyC1 Yes Yes Yes Yes Yes Yes 
HopPsyV1 Yes Yes No No No Yes 
HopPtoV No No No No No No 
HopPtoG Yes Yes No No Yes Yes 
 
a.   Rule 1:  Ile, Leu, Val, Ala or Pro in position 3 or 4, but not both. 
Rule 2:  Position 5 is rarely Met, Ile, Leu, Phenylalanine, Tryptophan, or 
Tyrosine. 
Rule 3:  Asp or Glu not present in first 12 positions. 
Rule 4.  Cys is rarely present in after position 5. 
Rule 5.  First 50 residues form an amphipathic helix rich in polar amino acids 
except Ser or Gln. 
Rule 6.  No more than 3 consecutive residues consisting of Met, Ile, Leu, Val, 




thought up to now.  It is likely that the secretion signal is actually a three-dimensional  
structure produced as a result of the interaction between the N-termini of effector 
proteins and one or more of the soluble components of the TTSS.  To date, almost all 
the data about the secretion signal has come from the Yersinia TTSS [7-9, 20, 29, 34, 
60, 116, 124, 127, 174, 184].  I believe that it is important to study the signal from 
many different species, since the similarities and slight differences between their 
TTSS might shed some light onto the actual nature of the signal.  Some of the studies 
that have attempted to elucidate the signal used alanine scanning of the first 15 
codons of the effector peptide [9].  Inserting an alanine might not have sufficiently 
disrupted the possible interactions with soluble components, and therefore I think it is 
necessary to carry out studies that more aggressively interrupt the N-terminus of 
various effectors.  These studies could use highly polar amino acids, in particular 
acidic residues, since the N-termini have been proposed to be basic [158].  
Alternatively, the studies could incorporate proline residues which would severely 
interfere with the secondary and tertiary structures of the peptides.   
 
For those effectors that interact with a chaperone, it is likely that the interaction leads 
to either the supramolecular structure required for the secretions signal, similar to 
what Birtalan, et al. propose [20], or allows the proper contact with the soluble 
components of the system, like FliJ or CesT [65, 141, 183].  An expensive and time-
consuming approach, but which ultimately may be the only way of clarifying the 
issue of the secretion signal, is resolving the three-dimensional structures of more 




of the TTSS, including those from flagellar biosynthesis.  These structures may help 
reveal the spatial organization of the secretion signal.  These approaches must all be 
combined with different bioinformatic tools that are becoming more capable of 
predicting hidden similarities.      
 
The knowledge of the secretion signal would be beneficial for several reasons. A 
thorough understanding of the secretion signal could allow us to predict other 
effectors in genomic data from both plant and animal pathogens, in similar fashion to 
how the knowledge of the hrpL-dependent promoters allowed identification of 
effectors in P. syringae [62].  Elucidating the whole artillery of each pathogen could 
help us better prevent and treat diseases in animals, humans, and plants.  For example, 
pharmaceuticals could be artificially produced that inhibit or prevent the function of 
one or more of the bacterial effector proteins.  An interesting novel application of 
understanding the secretion signal has been the production of fusion proteins for 
therapeutic functions.  For example, the TTSS-dependent delivery of the fusion 
products between YopE and Listeriolysin 0 or p60 from Listeria monocytogenes are 
currently being studied as a novel immunization method against listeriosis [166].  
Other therapeutic applications have recently been initiated with tumor-seeking, 
attenuated Salmonella, such that direct delivery of toxic proteins and/or surface-
localized antigens could be delivered into tumor cells to attack or induce an immune 
response against the tumor [129].  I believe that this form of “inverted pathogenicity” 
[166] holds great promise for future therapeutic treatments, not to mention the 
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